Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Osteoporosis

Free Subscription Articles published in Osteoporos Int Retrieve available abstracts of 448 articles: HTML format

Single Articles

October 2025
1. ABDALBARY M, Amin AM, Elaraby A, Hassan A, et al
   Efficacy and safety of romosozumab in patients with chronic kidney disease and osteoporosis: a narrative review.
   Osteoporos Int. 2025 Oct 31. doi: 10.1007/s00198-025-07707.
   PubMed     Abstract available
   
   
   
2. BUGBIRD AR, Burt LA, Whittier DE, Boyd SK, et al
   Localized bone deterioration predicts declining failure load and increased fracture risk.
   Osteoporos Int. 2025 Oct 29. doi: 10.1007/s00198-025-07750.
   PubMed     Abstract available
   
   
   
3. RAHMANI A, Weichelt U, Jahn D, Otto E, et al
   Beyond the initial impact: a systematic review of post-traumatic bone loss and its mechanisms.
   Osteoporos Int. 2025 Oct 28. doi: 10.1007/s00198-025-07716.
   PubMed     Abstract available
   
   
   
4. KIM J, Kwak S, Lee H, Chang J, et al
   Explainable opportunistic osteoporosis screening from chest X-rays: a retrospective comparison of foundation models.
   Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07727.
   PubMed     Abstract available
   
   
   
5. FALK SSI
   Author response to letter to the editor to ankle fractures: A pragmatic opportunity for osteoporosis case finding (OSIN-D-25-01889).
   Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07748.
   PubMed    
   
   
   
6. TSUKAMOTO M, Hamasaki T, Okimoto N, Saito Y, et al
   Author's response to letter to editor "Comment on: Effectiveness of treatment initiation for secondary fracture prevention in the older population: Japanese Bone-fracture Osteoporosis in Late-stage population Database study (J-BOLD)-emulation of a ran
   Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07739.
   PubMed    
   
   
   
7. SENDHIL SR, Cadarette SM, Aggarwal S, Oganisian A, et al
   Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries.
   Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07668.
   PubMed     Abstract available
   
   
   
8. HOSSEINPOUR M
   Clarifying the interpretation of metapgs and cumulative incidence in fracture risk prediction.
   Osteoporos Int. 2025 Oct 27. doi: 10.1007/s00198-025-07741.
   PubMed    
   
   
   
9. HUANG CC
   Ankle fractures: a pragmatic opportunity for osteoporosis case finding.
   Osteoporos Int. 2025 Oct 22. doi: 10.1007/s00198-025-07743.
   PubMed    
   
   
   
10. LO JC, Chandra M, Yang W, Darbinian JA, et al
    The association of bone density and hip fracture risk among Asian women.
    Osteoporos Int. 2025 Oct 22. doi: 10.1007/s00198-025-07663.
    PubMed     Abstract available
    
    
    
11. YILDIZ AE
    Letter to the editor: clinical presentation, risk factors and management of pregnancy?associated osteoporosis: a systematic review and meta?analysis.
    Osteoporos Int. 2025 Oct 21. doi: 10.1007/s00198-025-07723.
    PubMed    
    
    
    
12. PHUNG K, Rauch D, Jackowski S, Scharke M, et al
    Automated bone age calculation is an independent predictor of vertebral fracture burden in Duchenne muscular dystrophy.
    Osteoporos Int. 2025 Oct 21. doi: 10.1007/s00198-025-07681.
    PubMed     Abstract available
    
    
    
13. XU Z, Li Y, Song H, Sit RWS, et al
    The association of loneliness with bone mineral density, osteoporosis, osteopenia, fall, and sarcopenia among older adults: results from Mr. and Ms. Os (Hong Kong) study.
    Osteoporos Int. 2025 Oct 18. doi: 10.1007/s00198-025-07720.
    PubMed     Abstract available
    
    
    
14. NAYAK S, Greenspan SL
    A systematic review and meta-analysis of sequential treatment strategies for osteoporosis.
    Osteoporos Int. 2025 Oct 17. doi: 10.1007/s00198-025-07717.
    PubMed     Abstract available
    
    
    
15. TAKEGAMI Y, Imaizumi T, Sato K, Osawa Y, et al
    Impact of a national reimbursement policy on anti-osteoporosis medication prescription at discharge after hip-fracture surgery in Japan: an interrupted time-series analysis.
    Osteoporos Int. 2025 Oct 15. doi: 10.1007/s00198-025-07721.
    PubMed     Abstract available
    
    
    
16. KWAK MK, Lee S, Lee JY, Park JW, et al
    Differential fracture risk in breast cancer patients based on endocrine therapy and age: a nationwide cohort study.
    Osteoporos Int. 2025 Oct 15. doi: 10.1007/s00198-025-07639.
    PubMed     Abstract available
    
    
    
17. SEEFRIED L, Ferrari S, Pall D, Viapiana O, et al
    A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis.
    Osteoporos Int. 2025 Oct 14. doi: 10.1007/s00198-025-07711.
    PubMed     Abstract available
    
    
    
18. KAO SW, Huang YC, Chen YC, Cheng MT, et al
    Prevalence and risk factors of osteoporosis and fragility fractures in aging Hakka women in Taiwan.
    Osteoporos Int. 2025 Oct 14. doi: 10.1007/s00198-025-07666.
    PubMed     Abstract available
    
    
    
19. ADAMI G, Bartezaghi M, Montanari F, Piccinelli A, et al
    ROMosozumab early experience in female patients with severe osteoporosis in an Italian real-world setting, the ROMEO study.
    Osteoporos Int. 2025 Oct 13. doi: 10.1007/s00198-025-07722.
    PubMed     Abstract available
    
    
    
20. SIMPSON PM, Dobson AJ, Baneshi MR, Mishra GD, et al
    Age at diabetes diagnosis and fracture risk in women: a cohort study from the Australian Longitudinal Study on Women's Health.
    Osteoporos Int. 2025 Oct 12. doi: 10.1007/s00198-025-07710.
    PubMed     Abstract available
    
    
    
21. MACHADO M
    Insufficient evidence to recommend creatine supplementation as a therapeutic option for osteoporosis.
    Osteoporos Int. 2025 Oct 9. doi: 10.1007/s00198-025-07713.
    PubMed    
    
    
    
22. BEEKMAN MJ, Terra L, Stuursma A, Heemskerk-Gerritsen BAM, et al
    Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density.
    Osteoporos Int. 2025 Oct 4. doi: 10.1007/s00198-025-07679.
    PubMed     Abstract available
    
    
    September 2025
23. ALVI A, Parashar K, Siddiqui S, Arshad M, et al
    Therapeutic potential of fish collagen hydrolysates in osteoporosis prevention: a narrative review based on cellular, molecular, and clinical evidence.
    Osteoporos Int. 2025 Sep 30. doi: 10.1007/s00198-025-07698.
    PubMed     Abstract available
    
    
    
24. CHUN MY, Kim J
    Letters to the Editor: rebuttal to OSIN-D-25-01417R1 "Letter to the editor concerning "Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study"".
    Osteoporos Int. 2025 Sep 30. doi: 10.1007/s00198-025-07693.
    PubMed    
    
    
    
25. JHA V, Bhadada SK, Pal R, Kharbanda C, et al
    Personalizing denosumab therapy in postmenopausal Indian women with osteoporosis: predictive role of bone turnover markers and body mass index in determining dosing interval.
    Osteoporos Int. 2025 Sep 29. doi: 10.1007/s00198-025-07703.
    PubMed     Abstract available
    
    
    
26. HAN X, Xia M
    Letter to the editor concerning "Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study".
    Osteoporos Int. 2025 Sep 22. doi: 10.1007/s00198-025-07678.
    PubMed    
    
    
    
27. FALK SSI, Mittlmeier T
    Should we consider ankle fractures as osteoporotic fractures?
    Osteoporos Int. 2025 Sep 19. doi: 10.1007/s00198-025-07690.
    PubMed     Abstract available
    
    
    
28. ORHADJE E, Berg K, Whitehead K, Hauser B, et al
    Height loss, back pain and severe pain are highly predictive of pregnancy associated osteoporosis.
    Osteoporos Int. 2025 Sep 12. doi: 10.1007/s00198-025-07618.
    PubMed     Abstract available
    
    
    
29. MONTOYA-GARCIA MJ, Carbonell-Abella C, Garcia MG, Hernandez-Cruz B, et al
    Adequacy of pharmacological prescription in patients at very high risk of fracture within the FLS in Spain: analysis of the REFRA FLS-SEIOMM Registry.
    Osteoporos Int. 2025 Sep 12. doi: 10.1007/s00198-025-07565.
    PubMed     Abstract available
    
    
    
30. BOBELYAK M, Vaculik J, Stepan JJ
    Bone mineral density assessment using radiofrequency echographic multispectrometry (REMS) in patients before and after total hip replacement.
    Osteoporos Int. 2025 Sep 10. doi: 10.1007/s00198-025-07685.
    PubMed     Abstract available
    
    
    
31. LO SW, Yen HK, Huang CC, Lu YC, et al
    Incidence, risk factors, prognosis of periprosthetic fractures post hip fracture: unveiling protective role of anti-osteoporotic medication.
    Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07670.
    PubMed     Abstract available
    
    
    
32. ZHANG X, Xu D, Zhang R, Wang H, et al
    Interaction between diabetes and osteoporosis: imbalance between inflammation and bone remodeling.
    Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07636.
    PubMed     Abstract available
    
    
    
33. LIU Y, Arora T, Zhang J, Sen B, et al
    Socioeconomic vulnerability and osteoporosis treatment disparities during COVID-19 lockdown among U.S. medicare enrollees who initiated romosozumab.
    Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07677.
    PubMed     Abstract available
    
    
    
34. CLARK P, Calo M, Bostico ST, de Pedro AO, et al
    Latin American patients' perceptions on osteoporosis diagnosis and treatment: The IOF Patient Advisory Group in Latin America.
    Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07684.
    PubMed     Abstract available
    
    
    
35. CRUZ-PRIEGO GA, Araiza-Nava B, Mendez-Sanchez L, Vargas-Chanes D, et al
    Predictive capacity of fracture risk assessment tools: overview of systematic reviews.
    Osteoporos Int. 2025 Sep 8. doi: 10.1007/s00198-025-07642.
    PubMed     Abstract available
    
    
    
36. KONSTANTELOS N, Kim S, Cheung AM, Burden AM, et al
    The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose.
    Osteoporos Int. 2025 Sep 4. doi: 10.1007/s00198-025-07672.
    PubMed     Abstract available
    
    
    
37. TSUKAMOTO M, Hamasaki T, Okimoto N, Saito Y, et al
    Effectiveness of treatment initiation for secondary fracture prevention in the older population: Japanese Bone-fracture Osteoporosis in Late-stage population Database study (J-BOLD) - emulation of a randomized target trial.
    Osteoporos Int. 2025 Sep 4. doi: 10.1007/s00198-025-07687.
    PubMed     Abstract available
    
    
    
38. XIAO YJ, Zhou YY, Liu YQ
    Zoledronic acid-induced acute psychiatric disorder.
    Osteoporos Int. 2025;36:1767-1769.
    PubMed     Abstract available
    
    
    
39. KABRA A, Katzman WB, Lane NE, Giangregorio LM, et al
    OsteoStrong and bone health: a scoping review.
    Osteoporos Int. 2025;36:1521-1534.
    PubMed     Abstract available
    
    
    
40. LEE JH, Heo SJ, Kim KM, Lee JE, et al
    Trends in serum phosphate, calcium, and parathyroid hormone levels according to renal function following denosumab.
    Osteoporos Int. 2025;36:1661-1669.
    PubMed     Abstract available
    
    
    
41. PRASAD TN, Flora SS, Bhadada SK, Yadav U, et al
    Anti-resorptive and anabolic therapies improve Falls Risk Assessment Score (FRAS) in postmenopausal women with type 2 diabetes mellitus.
    Osteoporos Int. 2025;36:1633-1639.
    PubMed     Abstract available
    
    
    
42. LIN J, Tjokrosaputro PP, Ang BH, Chew CK, et al
    Prolonged hypercalcemia induced by teriparatide: a case report and literature review.
    Osteoporos Int. 2025;36:1763-1766.
    PubMed     Abstract available
    
    
    
43. BILLINGS E, Dash AS, Raphael J, Heilbronner AK, et al
    Skeletal risk factors for postoperative complications in older men undergoing spinal fusion surgery.
    Osteoporos Int. 2025;36:1547-1555.
    PubMed     Abstract available
    
    
    August 2025
44. GUTIERREZ-HERMOSILLO H, de Leon-Gonzalez ED
    Advantages of measuring hand grip strength in osteoporosis patients.
    Osteoporos Int. 2025 Aug 29. doi: 10.1007/s00198-025-07680.
    PubMed    
    
    
    
45. DE FORD C, Guridi M, Chen Y, Murphy AP, et al
    Exploring the natural history of bone mineral density in Duchenne muscular dystrophy: a systematic literature review.
    Osteoporos Int. 2025 Aug 29. doi: 10.1007/s00198-025-07651.
    PubMed     Abstract available
    
    
    
46. HIREDESAI AN, Holle AM, Payne CS, Beckett NC, et al
    Assessing endocrinology referral rates and osteoporosis directed-care after upper extremity fragility fractures.
    Osteoporos Int. 2025 Aug 27. doi: 10.1007/s00198-025-07665.
    PubMed     Abstract available
    
    
    
47. ZENG ZJ, PengPeng, Huang CL, Yao FM, et al
    More severe microdamage and micromechanical alterations: altered subchondral bone remodeling in varus knee osteoarthritis with osteoporosis.
    Osteoporos Int. 2025 Aug 27. doi: 10.1007/s00198-025-07652.
    PubMed     Abstract available
    
    
    
48. NGUYEN HG, Nguyen DT, Tran TS, Ling SH, et al
    Artificial intelligence system for predicting areal bone mineral density from plain X-rays.
    Osteoporos Int. 2025 Aug 27. doi: 10.1007/s00198-025-07634.
    PubMed     Abstract available
    
    
    
49. MCCLOSKEY EV, Johansson H, Liu E, Akesson KE, et al
    Family history of fracture and fracture risk: a meta-analysis to update the FRAX(R) risk assessment tool.
    Osteoporos Int. 2025 Aug 23. doi: 10.1007/s00198-025-07607.
    PubMed     Abstract available
    
    
    
50. JIN H, Jin H, Suk KS, Lee BH, et al
    Impact of anti-osteoporosis medication on refracture prevention following osteoporotic vertebral fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07661.
    PubMed     Abstract available
    
    
    
51. KO Y, Song BG, Shin H, Park Y, et al
    Correction: Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis.
    Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07649.
    PubMed    
    
    
    
52. HARVEY NC, Al-Daghri N, Beaudart C, Brandi ML, et al
    Barriers and solutions for global access to osteoporosis management: a Position Paper from the International Osteoporosis Foundation.
    Osteoporos Int. 2025 Aug 22. doi: 10.1007/s00198-025-07628.
    PubMed     Abstract available
    
    
    
53. LI CC, Ou LC, Chang YF, Chang CS, et al
    Performance and interventional cutoffs of osteoporosis self-assessment tools in the community: implications for screening and early referral.
    Osteoporos Int. 2025 Aug 20. doi: 10.1007/s00198-025-07656.
    PubMed     Abstract available
    
    
    
54. DU X, Nouraie SM, Pu J, Karoleski C, et al
    Lung-related risk factors associate with low bone mineral density in individuals with former tobacco exposure not meeting osteoporosis screening criteria.
    Osteoporos Int. 2025 Aug 19. doi: 10.1007/s00198-025-07648.
    PubMed     Abstract available
    
    
    
55. SCHOTT EM, Charbonneau MR, Kiel DP, Bukata S, et al
    A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal women.
    Osteoporos Int. 2025 Aug 15. doi: 10.1007/s00198-025-07650.
    PubMed     Abstract available
    
    
    
56. SIAMPANOPOULOU V, Ziogas DC, Lyrarakis G, Anastasopoulou A, et al
    Bone mineral density changes following immune checkpoint inhibitor therapy: insights from a case series analysis.
    Osteoporos Int. 2025 Aug 10. doi: 10.1007/s00198-025-07647.
    PubMed     Abstract available
    
    
    
57. CHUNG H, Kim TY, Kim J, Ha YC, et al
    Long-term trends of osteoporotic hip fractures in South Korea: analysis of National Health Insurance Data from 2006 to 2022.
    Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07537.
    PubMed     Abstract available
    
    
    
58. BORSATI A, Adamoli G, Giannarelli D, Belluomini L, et al
    Effect of exercise on bone-related outcomes in patients with cancer affected by bone metastases or bone loss: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07645.
    PubMed     Abstract available
    
    
    
59. GU Y, Wang Y, Li M, Wang R, et al
    Current applications of deep learning in vertebral fracture diagnosis.
    Osteoporos Int. 2025 Aug 6. doi: 10.1007/s00198-025-07604.
    PubMed     Abstract available
    
    
    
60. CASSINAT J, Wright V
    A cost-saving analysis of pharmacologic management in osteoporotic fracture prevention among postmenopausal women.
    Osteoporos Int. 2025 Aug 1. doi: 10.1007/s00198-025-07621.
    PubMed     Abstract available
    
    
    
61. PELEPENKO LE, de Oliveira MC, Masaro DA, Lustosa GMMM, et al
    Effects of microplastics on the bones: a comprehensive review.
    Osteoporos Int. 2025;36:1327-1345.
    PubMed     Abstract available
    
    
    
62. CHEN J, Cao L, Xu C, Lu F, et al
    Modified criteria for identifying elevated bone mass.
    Osteoporos Int. 2025;36:1433-1445.
    PubMed     Abstract available
    
    
    July 2025
63. CHUAN F, Mei M, Liao K, Ye X, et al
    DXA based radiomics scoring: a novel approach for fragility fracture risk assessment in elderly type 2 diabetes patients.
    Osteoporos Int. 2025 Jul 30. doi: 10.1007/s00198-025-07644.
    PubMed     Abstract available
    
    
    
64. WANG X, Ji C, Li S, Wang K, et al
    Quantitative computed tomography provides improved accuracy for diagnosis of lumbar osteoporosis in patients with facet joint osteoarthritis: a cross-sectional study.
    Osteoporos Int. 2025 Jul 27. doi: 10.1007/s00198-025-07600.
    PubMed     Abstract available
    
    
    
65. NIAZI S, Mazloomi M, Ostovar A, Fahimfar N, et al
    Fatty acid dietary intakes and blood concentrations in relation to hip fracture risk in adults: a systematic review and meta-analysis of prospective cohort studies.
    Osteoporos Int. 2025 Jul 27. doi: 10.1007/s00198-025-07587.
    PubMed     Abstract available
    
    
    
66. CHUN MY, Jeon J, Chung SJ, Kim J, et al
    Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study.
    Osteoporos Int. 2025 Jul 24. doi: 10.1007/s00198-025-07611.
    PubMed     Abstract available
    
    
    
67. LYU FF, Zhang M, Deng YF, Liu Q, et al
    Incidence and predictors of residual back pain after percutaneous vertebral augmentation in osteoporotic vertebral compression fracture: a systematic review and meta analysis.
    Osteoporos Int. 2025 Jul 23. doi: 10.1007/s00198-025-07609.
    PubMed     Abstract available
    
    
    
68. LIU L, Li D
    Letter to the editor concerning "The impact of a fracture liaison service with in?hospital anti?osteoporosis treatment on subsequent hip fracture and mortality rates-a single?center retrospective study".
    Osteoporos Int. 2025 Jul 17. doi: 10.1007/s00198-025-07433.
    PubMed    
    
    
    
69. GU HY, Liu N, Lin FX, Yin J, et al
    Nrf2 signaling pathway: focus on oxidative stress in osteoporosis.
    Osteoporos Int. 2025 Jul 15. doi: 10.1007/s00198-025-07592.
    PubMed     Abstract available
    
    
    
70. KNIGHT T, Eley S
    Postmenopausal osteoporosis continuing education needed for healthcare professionals? A quality improvement project.
    Osteoporos Int. 2025 Jul 15. doi: 10.1007/s00198-025-07571.
    PubMed     Abstract available
    
    
    
71. LUO Z, Feng A, Tyurin A, Cui Q, et al
    Testosterone, sex hormone-binding globulin, and fracture risk in men: evidence from observational and Mendelian randomization analyses.
    Osteoporos Int. 2025 Jul 15. doi: 10.1007/s00198-025-07620.
    PubMed     Abstract available
    
    
    
72. LLOPIS-CARDONA F, Rodriguez-Bernal CL, Hurtado I, Espallargues M, et al
    Contemporary pharmacological management of patients after hip fracture: a population-based cohort of over 120,000 patients in Spain.
    Osteoporos Int. 2025 Jul 12. doi: 10.1007/s00198-025-07564.
    PubMed     Abstract available
    
    
    
73. O'HARE B, Santaguida P, Azizudin AM, Papaioannou A, et al
    The role of physical performance measures in the physiotherapy assessment and management of older adults with osteoporotic vertebral fractures: a narrative review.
    Osteoporos Int. 2025 Jul 11. doi: 10.1007/s00198-025-07606.
    PubMed     Abstract available
    
    
    
74. ZOULAKIS M, Johansson H, Harvey NC, Axelsson KF, et al
    Effect of FRAXplus adjustments on fracture risk reclassification in older Swedish women-results from the SUPERB-study.
    Osteoporos Int. 2025 Jul 11. doi: 10.1007/s00198-025-07588.
    PubMed     Abstract available
    
    
    
75. KO Y, Song BG, Shin H, Park Y, et al
    Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis.
    Osteoporos Int. 2025 Jul 11. doi: 10.1007/s00198-025-07602.
    PubMed     Abstract available
    
    
    
76. XIA L, Chi H, Cao Q
    Letter to the editor about "the impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates-a single-center retrospective study".
    Osteoporos Int. 2025 Jul 7. doi: 10.1007/s00198-025-07432.
    PubMed    
    
    
    
77. HARISH S, Moon RJ, Harvey NC, Inskip HM, et al
    Maternal smoking before and during pregnancy and offspring bone mineral density in early childhood: findings from the Southampton Women's Survey.
    Osteoporos Int. 2025 Jul 2. doi: 10.1007/s00198-025-07581.
    PubMed     Abstract available
    
    
    
78. MAKRAS P, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, et al
    No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trial.
    Osteoporos Int. 2025;36:1231-1237.
    PubMed     Abstract available
    
    
    
79. FERRARI S, Akesson KE, Al-Daghri N, Biver E, et al
    Bone microstructure and TBS in diabetes: what have we learned? A narrative review.
    Osteoporos Int. 2025;36:1115-1128.
    PubMed     Abstract available
    
    
    June 2025
80. PARK J, Kim JW, Nam JH, Kim Y, et al
    Comparative analysis of osteoporotic versus pathologic fracture in metastatic colorectal cancer patients.
    Osteoporos Int. 2025 Jun 30. doi: 10.1007/s00198-025-07575.
    PubMed     Abstract available
    
    
    
81. DEMERS AJ, Fitton LS, McCulley SML, Delgado-Arellanes I, et al
    Fracture liaison service evaluation during admission for fragility femur fracture increases rates of bone health intervention and outpatient follow-up.
    Osteoporos Int. 2025 Jun 27. doi: 10.1007/s00198-025-07557.
    PubMed     Abstract available
    
    
    
82. ZHAO AY, Chiu A, Agarwal AR, Harris AB, et al
    The growing burden of periprosthetic fractures after total hip arthroplasty: identifying overall trends and at-risk groups.
    Osteoporos Int. 2025 Jun 26. doi: 10.1007/s00198-025-07583.
    PubMed     Abstract available
    
    
    
83. MCLAUGHLIN EC, Giangregorio LM, Adachi JD, Laing AC, et al
    Characterizing types and circumstances of fractures in the Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2025 Jun 25. doi: 10.1007/s00198-025-07435.
    PubMed     Abstract available
    
    
    
84. KAMIYA K, Kojima A, Tachiki T, Imai N, et al
    Joint association of milk intake and blood 25(OH)D levels with fracture risk in postmenopausal women: 20-year follow-up data from the Japanese Population-Based Osteoporosis cohort study.
    Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07577.
    PubMed     Abstract available
    
    
    
85. WANG H, Zhao Y, Liu Q, Jiang Z, et al
    Global burden of low bone mineral density related fractures in pre- and post-menopausal women from 1990 to 2021, with projections to 2050.
    Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07586.
    PubMed     Abstract available
    
    
    
86. MOON RJ, D'Angelo S, Curtis EM, Ward KA, et al
    Pregnancy vitamin D supplementation and bone mineral density of the mother: a post hoc analysis of the MAVIDOS randomised placebo-controlled trial.
    Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07568.
    PubMed     Abstract available
    
    
    
87. DING Q, Zhou B, Leung J, Kwok T, et al
    Global trends in burden of fractures, low bone mineral density, and high body mass index from 1990 to 2021, an age-period-cohort analysis.
    Osteoporos Int. 2025 Jun 17. doi: 10.1007/s00198-025-07570.
    PubMed     Abstract available
    
    
    
88. SHOGRY FF, Hayes KN, Kim S, Burden AM, et al
    The rise and fall of raloxifene use for osteoporosis, 1999-2022.
    Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07544.
    PubMed     Abstract available
    
    
    
89. MARSELOU E, Kelekis A, Dimitriadis Z, Koumantakis GA, et al
    Risk factors for refracture or new vertebral compression fractures after percutaneous vertebroplasty: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07523.
    PubMed     Abstract available
    
    
    
90. SON HJ, Park SJ, Park JS, Han K, et al
    Impact of smoking, diabetes, and exercise on dementia risk in women with osteoporosis: a nationwide cohort study.
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07524.
    PubMed     Abstract available
    
    
    
91. TAKEUCHI Y, Tanaka S, Kuroda T, Hagino H, et al
    Authors' response to 01460, renal dysfunction and its influence on osteoporosis treatment outcomes: a critical review of recent findings.
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-024-07293.
    PubMed    
    
    
    
92. CHEN J, Zhou Q, Yu W, Cao D, et al
    Renal dysfunction and its influence on osteoporosis treatment outcomes: a critical review of recent findings.
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07534.
    PubMed    
    
    
    
93. ZHANG Y, Ma M, Huang X, Liu J, et al
    Machine learning is changing osteoporosis detection: an integrative review.
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07541.
    PubMed     Abstract available
    
    
    
94. BUGBIRD AR, Matheson BE, Walle M, Neeteson NJ, et al
    Quantifying localized bone loss in clinical computed tomography using void spaces.
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07558.
    PubMed     Abstract available
    
    
    
95. CIROVIC A, Milovanovic P
    Can adjustment for iron, zinc, and calcium levels clarify the relationship between blood cadmium and bone mineral density?
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07434.
    PubMed    
    
    
    
96. HUANG CF, Ho CJ, Lin SY, Hwang JS, et al
    Asia-Pacific consensus for the management of osteoporosis in men.
    Osteoporos Int. 2025 Jun 4. doi: 10.1007/s00198-025-07559.
    PubMed     Abstract available
    
    
    
97. SHARAFI MH, Nazari A, Cheraghi M, Souri F, et al
    The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches.
    Osteoporos Int. 2025 Jun 2. doi: 10.1007/s00198-025-07553.
    PubMed     Abstract available
    
    
    
98. BISCHOFF-FERRARI HA, Dawson-Hughes B, Orav JE, Ceglia L, et al
    Effect of calcifediol and cholecalciferol on muscle function in postmenopausal women: a randomized controlled trial.
    Osteoporos Int. 2025;36:1007-1018.
    PubMed     Abstract available
    
    
    May 2025
99. RIPPL M, Grupp P, Martini S, Muller K, et al
    Characteristics and treatment options of 272,152 geriatric patients with very high and high fracture risk.
    Osteoporos Int. 2025 May 30. doi: 10.1007/s00198-025-07540.
    PubMed     Abstract available
    
    
    
100. CHENG R, Zhang L
     Case report on possible causes of severe osteoporosis: diffuse panbronchiolitis.
     Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07532.
     PubMed     Abstract available
     
     
     
101. MASHARAWI Y, Lerner A, Weisman A
     Transcultural adaptation and validation of the QUALEFFO-41 Questionnaire for Hebrew-Speaking Israeli women with postmenopausal osteoporosis with and without vertebral fractures.
     Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07526.
     PubMed     Abstract available
     
     
     
102. BERNATZ JT, Sandhu KP, Krueger D, Borchardt G, et al
     Trabecular bone score predicts distal femur screw pull-out strength better than DXA bone mineral density, CT Hounsfield units, and cortical density.
     Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07530.
     PubMed     Abstract available
     
     
     
103. LI H, Wang H
     Association between weekend warrior physical activity pattern and bone mineral density among adults: national health and nutrition examination survey.
     Osteoporos Int. 2025 May 26. doi: 10.1007/s00198-025-07535.
     PubMed     Abstract available
     
     
     
104. GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al
     Author response to: among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
     Osteoporos Int. 2025 May 23. doi: 10.1007/s00198-025-07520.
     PubMed    
     
     
     
105. MONEGAL A, Carrasco JL, Peris P, Frade-Sosa B, et al
     Results of the implementation of a multidisciplinary care protocol for preventing fragility fractures following liver transplantation.
     Osteoporos Int. 2025 May 22. doi: 10.1007/s00198-025-07525.
     PubMed     Abstract available
     
     
     
106. UM YJ, Cho IY, Koo HY, Park YM, et al
     Intellectual disabilities and risk of fractures: A population-based cohort study.
     Osteoporos Int. 2025 May 13. doi: 10.1007/s00198-025-07519.
     PubMed     Abstract available
     
     
     
107. PRAVEEN AD, Jha D, Baker A, Fleps I, et al
     Comparison of the time-dependent discriminatory accuracy of femoral strength and bone mineral density for predicting future hip and major osteoporotic fractures: a 16-year follow-up of the AGES-Reykjavik cohort.
     Osteoporos Int. 2025 May 12. doi: 10.1007/s00198-025-07503.
     PubMed     Abstract available
     
     
     
108. ORAVEC D, Yadav RN, Cushman T, Flynn MJ, et al
     Osteoporosis screening in the mammography setting via digital wrist tomosynthesis.
     Osteoporos Int. 2025 May 9. doi: 10.1007/s00198-025-07516.
     PubMed     Abstract available
     
     
     
109. LIU E, Liu RY, Moraros J, McCloskey EV, et al
     Association between walking and hip fracture in women aged 65 and older: 20-year follow-up from the study of osteoporotic fractures.
     Osteoporos Int. 2025 May 7. doi: 10.1007/s00198-025-07508.
     PubMed     Abstract available
     
     
     
110. WU Q, Jung J
     Precision fracture risk assessment: leveraging genomic and clinical data for personalized care.
     Osteoporos Int. 2025 May 6. doi: 10.1007/s00198-025-07517.
     PubMed    
     
     
     
111. OUYANG W, Guo G, Zhao C
     Comment on: The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.
     Osteoporos Int. 2025 May 2. doi: 10.1007/s00198-025-07430.
     PubMed    
     
     
     April 2025
112. HOUEL V, Marchasson G, Ramdane N, Philippoteaux C, et al
     Patients with periprosthetic femoral fractures are older adults who are commonly diagnosed with osteoporosis.
     Osteoporos Int. 2025 Apr 29. doi: 10.1007/s00198-025-07486.
     PubMed     Abstract available
     
     
     
113. ALBRECHT AP, Kistler-Fischbacher M, De Godoi Rezende Costa Molino C, Armbrecht G, et al
     Prevalence and incidence of osteoporotic vertebral fractures in community-dwelling European older adults: an observational analysis of the DO-HEALTH trial.
     Osteoporos Int. 2025 Apr 25. doi: 10.1007/s00198-025-07489.
     PubMed     Abstract available
     
     
     
114. ADAMS H, Salman L, Drinkwater KJ, Griffin J, et al
     Improved radiological diagnosis of osteoporotic vertebral fragility fractures following UK-wide interventions and re-audit-can this be maintained and translated into clinical practice?
     Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07488.
     PubMed     Abstract available
     
     
     
115. PIGNOLO RJ, Connell JJ, Briggs W, Kelly CJ, et al
     Opportunistic assessment of osteoporosis using hip and pelvic X-rays with OsteoSight: validation of an AI-based tool in a US population.
     Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07487.
     PubMed     Abstract available
     
     
     
116. GORGEY AS, Venigalla S, Deitrich JN, Ballance WB, et al
     Electrical stimulation paradigms on muscle quality and bone mineral density after spinal cord injury.
     Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07482.
     PubMed     Abstract available
     
     
     
117. IFTIKHAR QUA
     Bridging the gap: validating AI for real-world osteoporosis screening.
     Osteoporos Int. 2025 Apr 15. doi: 10.1007/s00198-025-07496.
     PubMed    
     
     
     
118. ORHADJE E, Makaram N, Berg K, Hauser B, et al
     Clinical presentation, risk factors and management of pregnancy-associated osteoporosis: a systematic review and meta-analysis.
     Osteoporos Int. 2025 Apr 9. doi: 10.1007/s00198-025-07479.
     PubMed     Abstract available
     
     
     
119. LO HZ, Leow K, Hii R, Nerlekar N, et al
     Effect of osteoporosis medications on vascular and valvular calcification: a systematic review and meta-analysis.
     Osteoporos Int. 2025 Apr 7. doi: 10.1007/s00198-025-07468.
     PubMed     Abstract available
     
     
     
120. LI J, Fu X, Shi H, Jing J, et al
     Protective role of irisin on bone in osteoporosis: a systematic review of rodent studies.
     Osteoporos Int. 2025 Apr 7. doi: 10.1007/s00198-025-07470.
     PubMed     Abstract available
     
     
     
121. BAUMANN AN, Krez AN, Trager RJ, Anaspure OS, et al
     Osteoporosis is not associated with increased reoperation or fracture risk three years after total ankle arthroplasty: a retrospective cohort study.
     Osteoporos Int. 2025 Apr 4. doi: 10.1007/s00198-025-07473.
     PubMed     Abstract available
     
     
     
122. HAYES KN, Zullo AR, Berry SD, Oganisian A, et al
     Osteoporosis medication use over time in the United States and Canada.
     Osteoporos Int. 2025 Apr 2. doi: 10.1007/s00198-025-07484.
     PubMed     Abstract available
     
     
     
123. LIU L, Wang Y, Tan B, Huang P, et al
     Association of beta-adrenergic receptor blockers use with the risk of fracture in adults: a systematic review and meta-analysis.
     Osteoporos Int. 2025 Apr 2. doi: 10.1007/s00198-025-07471.
     PubMed     Abstract available
     
     
     
124. GATINEAU G, Hind K, Shevroja E, Gonzalez-Rodriguez E, et al
     Advancing trabecular bone score (TBS): clinical performance of TBS version 4.0 with direct correction for soft tissue thickness-the osteolaus study.
     Osteoporos Int. 2025;36:715-724.
     PubMed     Abstract available
     
     
     
125. KHAN AA, AbuAlrob H, Ali DS, Al Kassem Z, et al
     Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR).
     Osteoporos Int. 2025;36:673-684.
     PubMed     Abstract available
     
     
     
126. VARENNA M, Zucchi F, Di Taranto R, Orsini F, et al
     Osteoclast in CRPS: an alleged guilty fully acquitted.
     Osteoporos Int. 2025;36:737-740.
     PubMed     Abstract available
     
     
     
127. PATINO-SALAZAR JD, Ovejero D, Gabernet M, Martinez-Gil N, et al
     Identifying rare variants in genes related to bone phenotypes in a cohort of postmenopausal women.
     Osteoporos Int. 2025;36:637-644.
     PubMed     Abstract available
     
     
     
128. WOLF JVE, Schoene D, Kohl M, Kemmler W, et al
     Effects of combined protein and exercise interventions on bone health in middle-aged and older adults - A systematic literature review and meta-analysis of randomized controlled trials.
     Osteoporos Int. 2025;36:609-625.
     PubMed     Abstract available
     
     
     March 2025
129. BHATTOA HP, Vasikaran S, Trifonidi I, Kapoula G, et al
     Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), Internatio
     Osteoporos Int. 2025 Mar 28. doi: 10.1007/s00198-025-07422.
     PubMed     Abstract available
     
     
     
130. PAN Y, Wan Y, Wang Y, Yu T, et al
     Conventional chest computed tomography-based radiomics for predicting the risk of thoracolumbar osteoporotic vertebral fractures.
     Osteoporos Int. 2025 Mar 27. doi: 10.1007/s00198-024-07338.
     PubMed     Abstract available
     
     
     
131. MARKARIAN AM, Taaffe DR, Bettariga F, Luo H, et al
     Bone mineral density in childhood cancer survivors during and after oncological treatment: A systematic review and meta-analysis.
     Osteoporos Int. 2025 Mar 27. doi: 10.1007/s00198-025-07458.
     PubMed     Abstract available
     
     
     
132. BEAUDART C, Veronese N, Douxfils J, Thiyagarajan JA, et al
     Correction: PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.
     Osteoporos Int. 2025 Mar 26. doi: 10.1007/s00198-025-07452.
     PubMed    
     
     
     
133. SOPINA L, Hitz MF, Thygesen LC, Langdahl B, et al
     Healthcare and productivity cost of osteoporosis: a Danish register-based quasi-experimental study.
     Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07453.
     PubMed     Abstract available
     
     
     
134. GERDHEM P, Wihlborg A, Bergstrom IB
     Site-specific volumetric skeletal changes in women with and without a distal forearm fracture: a case-control study with a mean 7-year follow-up.
     Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07412.
     PubMed     Abstract available
     
     
     
135. SHAHZAD UB, Hanif U, Aiman U
     From bisphosphonates to advanced therapies: a critical review of osteoporosis treatment strategies.
     Osteoporos Int. 2025 Mar 19. doi: 10.1007/s00198-025-07457.
     PubMed    
     
     
     
136. YUKISHIMA T, Ebina K, Etani Y, Noguchi T, et al
     Author response to letter to the editor, (OSIN-D-25-00227) "From bisphosphonates to advanced therapies: a critical review of osteoporosis treatment strategies".
     Osteoporos Int. 2025 Mar 19. doi: 10.1007/s00198-025-07466.
     PubMed    
     
     
     
137. PARK JH, Kwon O, Choi JH, Yeom JS, et al
     Perioperative teriparatide for preventing proximal junctional kyphosis and failure in patients with osteoporosis after adult thoracolumbar spinal deformity surgery: a prospective randomized controlled trial.
     Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07449.
     PubMed     Abstract available
     
     
     
138. STARUP-LINDE J, Stoy J, Grinderslev PB, Langdahl B, et al
     Prevalence and risk factors for osteoporosis in type 1 diabetes-results from an observational study.
     Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07443.
     PubMed     Abstract available
     
     
     
139. GHASEMINEJAD-RAEINI A, Hoveidaei AH, Zarepour F, Taghavi SP, et al
     Notable lacking of bone mineral density measurement in cushing syndrome: a nationwide study based on the US insurance claim database.
     Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07418.
     PubMed     Abstract available
     
     
     
140. PARK JW, Kim HY, Kim KM, Kim J, et al
     Epidemiology of osteoporotic ankle fractures in South Korea: a nationwide retrospective cohort study (2006-2022).
     Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07429.
     PubMed     Abstract available
     
     
     
141. BEAUDART C, Veronese N, Douxfils J, Thiyagarajan JA, et al
     PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.
     Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07440.
     PubMed     Abstract available
     
     
     
142. ZHANG Q, Gao W, Xu X, Cui R, et al
     Elevated baseline CTX levels predict enhanced therapeutic efficacy of zoledronic acid in augmenting lumbar spine bone mineral density among Chinese osteoporosis patients.
     Osteoporos Int. 2025 Mar 4. doi: 10.1007/s00198-025-07448.
     PubMed     Abstract available
     
     
     
143. ENRIQUE LR, Francisco TN, Inigo EF, Cristina OT, et al
     Evidence-based joint statement position of perioperative bone optimization in the arthroplasty candidate, from FEMECOT, AMMOM, ACOMM, SCCOT, SECOT, SEFRAOS, SEIOMM.
     Osteoporos Int. 2025;36:375-389.
     PubMed     Abstract available
     
     
     
144. ZHOU K, Zhu Y, Luo X, Yang S, et al
     A novel hybrid deep learning framework based on biplanar X-ray radiography images for bone density prediction and classification.
     Osteoporos Int. 2025;36:521-530.
     PubMed     Abstract available
     
     
     
145. LAURSEN N, Solling AS, Harslof T, Langdahl B, et al
     Clinical experience with denosumab discontinuation.
     Osteoporos Int. 2025;36:435-446.
     PubMed     Abstract available
     
     
     February 2025
146. PETERSEN TG, Rubin KH, Javaid MK, Hermann AP, et al
     Long-term adherence to anti-osteoporosis medication and determinants of adherence in the population-based screening trial ROSE.
     Osteoporos Int. 2025 Feb 24. doi: 10.1007/s00198-025-07436.
     PubMed     Abstract available
     
     
     
147. LIU J, Zhang Y, Yu W, Sun L, et al
     TBS as a complementary tool for assessing vertebral fractures and spinal deformity in children and adolescents with osteogenesis imperfecta.
     Osteoporos Int. 2025 Feb 24. doi: 10.1007/s00198-025-07423.
     PubMed     Abstract available
     
     
     
148. KANIS JA, Johansson H, McCloskey EV, Liu E, et al
     Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX.
     Osteoporos Int. 2025 Feb 16. doi: 10.1007/s00198-025-07397.
     PubMed     Abstract available
     
     
     
149. ONTAN MS, Isik AT
     Author response to: OSIN-D-24-01894 comment on "Osteoporosis in older patients with idiopathic normal pressure hydrocephalus".
     Osteoporos Int. 2025 Feb 12. doi: 10.1007/s00198-025-07387.
     PubMed    
     
     
     
150. MO S, Gu Y
     Comment on "Osteoporosis in older patients with idiopathic normal pressure hydrocephalus".
     Osteoporos Int. 2025 Feb 11. doi: 10.1007/s00198-025-07416.
     PubMed    
     
     
     
151. CHEN R, Gong K, Chen W, Chen Z, et al
     Author response to: OSIN-D-24-01898: Comment on "Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005-2018".
     Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07388.
     PubMed    
     
     
     
152. SHAO J, Zhang H, Fei Q
     Comment on "Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005-2018".
     Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07417.
     PubMed    
     
     
     
153. LO JC, Chandra M, Khan MM, Barzilay J, et al
     Changing trends in bisphosphonate therapy: a twenty-five-year surveillance in a single US integrated healthcare system.
     Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-024-07372.
     PubMed     Abstract available
     
     
     
154. MAKKAR B, Obremskey W, Avidano R, Ott S, et al
     The definition of atypical femoral fractures should include periprosthetic femoral fractures (PAFFs).
     Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07401.
     PubMed     Abstract available
     
     
     
155. NAKAJIMA K, Horii C, Kodama H, Shirokoshi T, et al
     Association between vertebral fractures and brain volume: insights from a community cohort study.
     Osteoporos Int. 2025 Feb 5. doi: 10.1007/s00198-025-07403.
     PubMed     Abstract available
     
     
     
156. TICINESI A, Siniscalchi C, Meschi T, Nouvenne A, et al
     Gut microbiome and bone health: update on mechanisms, clinical correlations, and possible treatment strategies.
     Osteoporos Int. 2025;36:167-191.
     PubMed     Abstract available
     
     
     
157. BINKLEY N, Sempos CT, Borchardt G, Larsen J, et al
     Association of standardized serum 25-hydroxyvitamin D with falls in post-menopausal women.
     Osteoporos Int. 2025;36:255-264.
     PubMed     Abstract available
     
     
     January 2025
158. NOOR A, Nabi R, Khan HT, Noor A, et al
     Bridging the gap: enhancing osteoporosis management through AI-driven predictive models.
     Osteoporos Int. 2025 Jan 29. doi: 10.1007/s00198-025-07396.
     PubMed    
     
     
     
159. KAWAMURA K, Murata S, Kitano Y, Mera Y, et al
     Metaphyseal comminution in distal radius fractures: a predictor of secondary fragility fractures and the role of osteoporosis treatment.
     Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07404.
     PubMed     Abstract available
     
     
     
160. NASO CM, Lin SY, Song G, Xue H, et al
     Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA, 2005-2018.
     Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07395.
     PubMed     Abstract available
     
     
     
161. BROOKS ELG, Tangney CC, Ritz EM
     Ultra-processed food intake and prevalence of osteoporosis in US adults aged 50 years and older: a cross-sectional analysis.
     Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07394.
     PubMed     Abstract available
     
     
     
162. PATRA S
     Response to the letter "OSIN-24-D-01312, letter to the editor commenting on 'evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case-control study from India'".
     Osteoporos Int. 2025 Jan 23. doi: 10.1007/s00198-024-07354.
     PubMed    
     
     
     
163. YUKISHIMA T, Ebina K, Etani Y, Noguchi T, et al
     Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case-control study.
     Osteoporos Int. 2025 Jan 16. doi: 10.1007/s00198-025-07386.
     PubMed     Abstract available
     
     
     
164. LI X, Cheng L
     The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions.
     Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-025-07389.
     PubMed    
     
     
     
165. DURBIN JW, Zhao AY, Cui E, Agarwal AR, et al
     Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020.
     Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-025-07385.
     PubMed     Abstract available
     
     
     
166. LIU Z, Tian M, Duan L
     Enhancing emergency management for osteoporotic patients: a commentary on physical activity and mortality insights.
     Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-024-07371.
     PubMed    
     
     
     
167. LEE S, Hong N, Cho SJ, Shin S, et al
     Effect of romosozumab on bone mineral density and trabecular bone score in premenopausal women with low bone mass.
     Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-024-07336.
     PubMed     Abstract available
     
     
     
168. ANDREASEN C, Dahl C, Frihagen F, Borgen TT, et al
     Fracture liaison service (FLS) is associated with lower subsequent fragility fracture risk and mortality: NoFRACT (the Norwegian capture the fracture initiative).
     Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-024-07376.
     PubMed     Abstract available
     
     
     
169. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
     Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
     Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-025-07383.
     PubMed    
     
     
     
170. HUANG Z, Liao TC, Chuang AT, Shao SC, et al
     Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study.
     Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07381.
     PubMed     Abstract available
     
     
     
171. CAO D, Cao Z, Liu A
     Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
     Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07374.
     PubMed    
     
     
     
172. CHEN F, Luo J, Li L
     The association between blood cadmium levels and bone mineral density in U.S. adolescents aged 12-19 years.
     Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07349.
     PubMed     Abstract available
     
     
     
173. BUGBIRD AR, Boisvert NMJ, Burt LA, Boyd SK, et al
     Choose your mother wisely: the familial resemblance of bone adaptation.
     Osteoporos Int. 2025;36:141-149.
     PubMed     Abstract available
     
     
     December 2024
174. RAMSCHUTZ C, Sollmann N, El Husseini M, Kupfer K, et al
     Cervicothoracic volumetric bone mineral density assessed by opportunistic QCT may be a reliable marker for osteoporosis in adults.
     Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07373.
     PubMed     Abstract available
     
     
     
175. ALHARTHY A
     Assessment of trabecular bone Hounsfield units in the lumbar spine for osteoporosis evaluation in individuals aged 65 and above: a review.
     Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07340.
     PubMed     Abstract available
     
     
     
176. YUE X, Shi S
     Error in Mendelian randomization analysis in "Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma".
     Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07344.
     PubMed    
     
     
     
177. LIN YC, Chiang PH, Huang JY, Wu WS, et al
     Osteoporotic fracture risks of thiazides and dihydropyridines in angiotensin modulator users.
     Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07356.
     PubMed     Abstract available
     
     
     
178. NAGENDRA L, Chandran M, Reginster JY, Bhadada SK, et al
     Cost-effectiveness of FRAX(R)-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis.
     Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07328.
     PubMed     Abstract available
     
     
     
179. BLAKE RJ, Melemai VK, Fitzpatrick BM, Hubbard DF, et al
     Bilateral femoral neck fractures in pregnancy suggestive of transient osteoporosis of the hip in a patient with hyperparathyroidism: a case report.
     Osteoporos Int. 2024 Dec 24. doi: 10.1007/s00198-024-07346.
     PubMed     Abstract available
     
     
     
180. YOEL U, Alkobi Weiss H, Goldbart A, Silverman Siris E, et al
     The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates-a single-center retrospective study.
     Osteoporos Int. 2024 Dec 18. doi: 10.1007/s00198-024-07325.
     PubMed     Abstract available
     
     
     
181. CAO D, Chen J, Yu W
     Comment on: Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
     Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07306.
     PubMed    
     
     
     
182. ERDEN Y, Temel MH, Bagcier F
     Author response to: OSIN-D-24-00381, artificial intelligence insights into osteoporosis.
     Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07323.
     PubMed    
     
     
     
183. PARK HJ, Kim MG, Yoo YS, Lee B, et al
     Correction: determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: a systematic review and meta-analysis.
     Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07335.
     PubMed    
     
     
     
184. SONI M, Shabil M, Sah S
     Comment on "Association of proton-density fat fraction with osteoporosis: a systematic review and meta-analysis".
     Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07350.
     PubMed    
     
     
     
185. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
     Author Response to: Comment from Zahra Ali Haque, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan
     Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07332.
     PubMed    
     
     
     
186. VAN OOSTWAARD M, van den Bergh JP, Wyers CE
     Author response to 01530, Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.
     Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07322.
     PubMed    
     
     
     
187. RAZA MH, Bhutta ME, Siddique MH
     Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.
     Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07330.
     PubMed    
     
     
     
188. NARLA RR, Adler RA
     Rationale for osteoporosis screening in men.
     Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07337.
     PubMed     Abstract available
     
     
     
189. KIM CH, Kim K, Kim JW
     The effect of denosumab on minimum 3-years BMD changes in patients with osteoporotic hip fractures: a propensity score matching analysis.
     Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07314.
     PubMed     Abstract available
     
     
     
190. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
     Author Response to: Comment from Cheng Gu and Yu Cui on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
     Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07333.
     PubMed    
     
     
     
191. GU C, Cui Y
     Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
     Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07327.
     PubMed    
     
     
     
192. SALMORAL A, Peris P, Lopez Medina C, Florez H, et al
     Bisphosphonate drug holidays in osteoporosis according to fracture risk profile.
     Osteoporos Int. 2024 Dec 3. doi: 10.1007/s00198-024-07309.
     PubMed     Abstract available
     
     
     
193. PASQUINUCCI E, Limardo M, Salerno FR, Luise CM, et al
     Denosumab-associated symptomatic hypophosphatemia in normal kidney function: two case reports.
     Osteoporos Int. 2024;35:2231-2234.
     PubMed     Abstract available
     
     
     
194. MARTIN DP 2ND, Lake S, Behun M, Krueger D, et al
     Intraoperative physician assessment during total hip arthroplasty correlates with DXA parameters.
     Osteoporos Int. 2024;35:2145-2151.
     PubMed     Abstract available
     
     
     
195. TSAI JN, Jordan M, Lee H, Leder BZ, et al
     One versus 2 years of alendronate following denosumab: the CARD extension.
     Osteoporos Int. 2024;35:2225-2230.
     PubMed     Abstract available
     
     
     
196. RATHMANN W, Kostev K
     Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: a primary care cohort study.
     Osteoporos Int. 2024;35:2099-2106.
     PubMed     Abstract available
     
     
     November 2024
197. CHEN R, Gong K, Chen W, Chen Z, et al
     Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005-2018.
     Osteoporos Int. 2024 Nov 29. doi: 10.1007/s00198-024-07324.
     PubMed     Abstract available
     
     
     
198. AZAD TD, Wu RJ, Anderson KE, Darden M, et al
     Osteoporosis testing and treatment remain low in both Traditional Medicare and Medicare Advantage.
     Osteoporos Int. 2024 Nov 21. doi: 10.1007/s00198-024-07318.
     PubMed     Abstract available
     
     
     
199. ONTAN MS, Cam Mahser A, Dost FS, Isik AT, et al
     Osteoporosis in older patients with idiopathic normal pressure hydrocephalus.
     Osteoporos Int. 2024 Nov 18. doi: 10.1007/s00198-024-07317.
     PubMed     Abstract available
     
     
     
200. DE BRUIN IJA, Wyers CE, Vranken L, Schousboe JT, et al
     Systematic evaluation of abdominal aortic calcification in patients with a recent clinical fracture visiting the Fracture Liaison Service.
     Osteoporos Int. 2024 Nov 12. doi: 10.1007/s00198-024-07288.
     PubMed     Abstract available
     
     
     
201. DAUNGSUPAWONG H, Wiwanitkit V
     Artificial intelligence insights into osteoporosis: comment.
     Osteoporos Int. 2024 Nov 7. doi: 10.1007/s00198-024-07102.
     PubMed    
     
     
     October 2024
202. EVERTS-GRABER J, Reichenbach S, Lehmann T
     Response to the Letter to the Editor regarding "The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland" by Yang and colleagues.
     Osteoporos Int. 2024 Oct 28. doi: 10.1007/s00198-024-07282.
     PubMed    
     
     
     
203. YANG J, Cao D, Liu A
     Letter to the Editor Regarding "The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland".
     Osteoporos Int. 2024 Oct 28. doi: 10.1007/s00198-024-07281.
     PubMed    
     
     
     
204. CAO D, Gu N, Liu A
     Comment on: Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
     Osteoporos Int. 2024 Oct 23. doi: 10.1007/s00198-024-07248.
     PubMed    
     
     
     
205. ADESINA OO, Jenkins IC, Galvao F, de Moura AC, et al
     Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis.
     Osteoporos Int. 2024 Oct 22. doi: 10.1007/s00198-024-07268.
     PubMed     Abstract available
     
     
     
206. ZHOU K, Li R, Wang J
     Letter to the editor concerning "Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis".
     Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07287.
     PubMed    
     
     
     
207. HIRATA RP, Thomsen MJ, Liston M, Christensen MG, et al
     Letter to editor: rebuttal to OSIN-D-24-01254 "RE: Clinical features of fallers and non-fallers: Finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among older
     Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07257.
     PubMed    
     
     
     
208. DAUNGSUPAWONG H, Wiwanitkit V
     RE: Clinical features of fallers and non-fallers: Finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among older adults with and without osteoporosis.
     Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07256.
     PubMed    
     
     
     
209. SHARMA M, Beaudart C, Clark P, Fujiwara S, et al
     Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project.
     Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07264.
     PubMed     Abstract available
     
     
     
210. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
     Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
     Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07284.
     PubMed     Abstract available
     
     
     
211. CARDINALI DP, Reiter RJ
     Clinical use of melatonin in osteoporosis: Expectations still unmet.
     Osteoporos Int. 2024 Oct 18. doi: 10.1007/s00198-024-07261.
     PubMed    
     
     
     
212. PERSSON R, Hagberg KW, Pranschke E, Vasilakis-Scaramozza C, et al
     Treatment for osteoporosis and risk of osteonecrosis of the jaw among female patients in the United Kingdom Clinical Practice Research Datalink.
     Osteoporos Int. 2024 Oct 14. doi: 10.1007/s00198-024-07262.
     PubMed     Abstract available
     
     
     
213. DU J, Cui H, Zhao Y, Xue H, et al
     Correction: Exposure to air pollution might decrease bone mineral density and increase the prevalence of osteoporosis: A mendelian randomization study.
     Osteoporos Int. 2024 Oct 10. doi: 10.1007/s00198-024-07271.
     PubMed    
     
     
     
214. CHEN H, Lou Y, Fei S, Luo J, et al
     Association between physical activity and mortality in patients with osteoporosis: a cohort study of NHANES.
     Osteoporos Int. 2024 Oct 10. doi: 10.1007/s00198-024-07280.
     PubMed     Abstract available
     
     
     
215. BORGSTROM F, Lorentzon M, Johansson H, Harvey NC, et al
     Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK.
     Osteoporos Int. 2024 Oct 4. doi: 10.1007/s00198-024-07251.
     PubMed     Abstract available
     
     
     
216. AWAN EF, Farooqi HA, Nabi R
     Advancing bone health strategies in Duchenne muscular dystrophy: the role of BMD monitoring in transforming prognosis.
     Osteoporos Int. 2024;35:1865-1866.
     PubMed    
     
     
     
217. DENG X, Wu X, Sun Z, Liu Q, et al
     Associations between new obesity indices and abnormal bone density in type 2 diabetes mellitus patients.
     Osteoporos Int. 2024;35:1807-1815.
     PubMed     Abstract available
     
     
     September 2024
218. TAKEUCHI Y, Tanaka S, Kuroda T, Hagino H, et al
     Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05.
     Osteoporos Int. 2024 Sep 30. doi: 10.1007/s00198-024-07260.
     PubMed     Abstract available
     
     
     
219. GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al
     Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
     Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07240.
     PubMed     Abstract available
     
     
     
220. MASUDA S, Fukasawa T, Matsuda S, Yoshida S, et al
     Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study.
     Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07255.
     PubMed     Abstract available
     
     
     
221. DU J, Cui H, Zhao Y, Xue H, et al
     Exposure to air pollution might decrease bone mineral density and increase the prevalence of osteoporosis: a Mendelian randomization study.
     Osteoporos Int. 2024 Sep 23. doi: 10.1007/s00198-024-07249.
     PubMed     Abstract available
     
     
     
222. CAMPISI G, Mauceri R, Coppini M, Bedogni A, et al
     Correction: Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?".
     Osteoporos Int. 2024 Sep 18. doi: 10.1007/s00198-024-07245.
     PubMed    
     
     
     
223. ZHAO AS, Liu Y, Mulvey JJ, Tchang BG, et al
     Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report.
     Osteoporos Int. 2024 Sep 17. doi: 10.1007/s00198-024-07243.
     PubMed     Abstract available
     
     
     
224. GHASEMINEJAD-RAEINI A, Azarboo A, Zareshahi N, Jalali S, et al
     Early-life famine exposure and risk of osteoporosis and low bone mineral density: a systematic review and meta-analysis.
     Osteoporos Int. 2024 Sep 13. doi: 10.1007/s00198-024-07250.
     PubMed     Abstract available
     
     
     
225. ARMUTCU F, McCloskey E
     Insulin resistance, bone health, and fracture risk.
     Osteoporos Int. 2024 Sep 12. doi: 10.1007/s00198-024-07227.
     PubMed     Abstract available
     
     
     
226. JAIN RK
     Comment on article "Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force Report on Clinical Algorithms for Fracture Risk".
     Osteoporos Int. 2024 Sep 4. doi: 10.1007/s00198-024-07242.
     PubMed    
     
     
     
227. MAHMUD M, Muscatello DJ, Rahman MB, Osborne NJ, et al
     Association between socioeconomic deprivation and bone health status in the UK biobank cohort participants.
     Osteoporos Int. 2024;35:1573-1584.
     PubMed     Abstract available
     
     
     August 2024
228. LIN CJ, Liu SJ, Lin KY
     Author response to OSIN-D-24-00958 comment on: the association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
     Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07201.
     PubMed    
     
     
     
229. LI J, Zheng J
     Comment on: The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
     Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07200.
     PubMed    
     
     
     
230. HIRATA RP, Thomsen MJ, Liston M, Christensen MG, et al
     Clinical features of fallers and non-fallers: finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among older adults with and without osteoporosis.
     Osteoporos Int. 2024 Aug 24. doi: 10.1007/s00198-024-07233.
     PubMed     Abstract available
     
     
     
231. FAN Z, Zhao J, Chen J, Hu W, et al
     Causal associations of osteoporosis with stroke: a bidirectional Mendelian randomization study.
     Osteoporos Int. 2024 Aug 24. doi: 10.1007/s00198-024-07235.
     PubMed     Abstract available
     
     
     
232. KHADIVI G, Akhtari A, Sharifi F, Zargarian N, et al
     Diagnostic accuracy of artificial intelligence models in detecting osteoporosis using dental images: a systematic review and meta-analysis.
     Osteoporos Int. 2024 Aug 23. doi: 10.1007/s00198-024-07229.
     PubMed     Abstract available
     
     
     
233. CAMPISI G, Mauceri R, Coppini M, Bedogni A, et al
     Author Response to Letter to Editor regarding "Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?".
     Osteoporos Int. 2024 Aug 16. doi: 10.1007/s00198-024-07192.
     PubMed    
     
     
     
234. TRAN TS, Bliuc D, Blank RD, Center JR, et al
     Fracture risk assessment in the presence of competing risk of death.
     Osteoporos Int. 2024 Aug 15. doi: 10.1007/s00198-024-07224.
     PubMed     Abstract available
     
     
     
235. TAO J, Li H, Wang H, Tan J, et al
     Metabolic dysfunction-associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity.
     Osteoporos Int. 2024 Aug 13. doi: 10.1007/s00198-024-07217.
     PubMed     Abstract available
     
     
     
236. YUAN K, Liu Q, Luo P, Wang C, et al
     Association of proton-density fat fraction with osteoporosis: a systematic review and meta-analysis.
     Osteoporos Int. 2024 Aug 12. doi: 10.1007/s00198-024-07220.
     PubMed     Abstract available
     
     
     
237. MCCARROLL K, Fitzpatrick D, Lannon R
     Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
     Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07218.
     PubMed    
     
     
     
238. KUMAR S, Gild ML, McDonald MM, Kim AS, et al
     Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
     Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07214.
     PubMed    
     
     
     
239. WANG L, Guo X, Qin J, Jin Z, et al
     Assessing the causal relationship between plasma proteins and osteoporosis: novel insights into pathological mechanisms and therapeutic implications.
     Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07225.
     PubMed     Abstract available
     
     
     
240. ZENG Y, Yang Y, Wang J, Meng G, et al
     The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.
     Osteoporos Int. 2024 Aug 8. doi: 10.1007/s00198-024-07191.
     PubMed     Abstract available
     
     
     
241. HADJI P, Kamali L, Thomasius F, Horas K, et al
     Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER((R)) and high-resolution peripheral co
     Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07208.
     PubMed     Abstract available
     
     
     
242. KIRK JM, Rathbun AM, Gruber-Baldini AL, Hochberg MC, et al
     Sex differences and predictors of anti-osteoporosis medication use in the 12 months after hip fracture surgery in adults 65 or older.
     Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07211.
     PubMed     Abstract available
     
     
     
243. HU F, Li X, Zhao D, Chen C, et al
     The diagnostic value of MRI-based vertebral bone quality score for osteoporosis or osteopenia in patients undergoing lumbar surgery: a meta-analysis.
     Osteoporos Int. 2024 Aug 1. doi: 10.1007/s00198-024-07190.
     PubMed     Abstract available
     
     
     
244. KANIS JA, Dawson-Hughes B, Campusano C, Cooper C, et al
     IOF position on scientists and societies operating in conflict zones.
     Osteoporos Int. 2024;35:1323-1328.
     PubMed     Abstract available
     
     
     July 2024
245. PADERNO A, Gomes EJA, Gilberg L, Maerkisch L, et al
     Correction to: Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review.
     Osteoporos Int. 2024 Jul 31. doi: 10.1007/s00198-024-07206.
     PubMed    
     
     
     
246. TAYLOR L, Matsunaga M, Ahn HJ, Siu AM, et al
     Risk factors associated with 1-year mortality after osteoporotic hip fracture in Hawai'i: higher mortality risk among Native Hawaiians and other Pacific Islanders.
     Osteoporos Int. 2024 Jul 30. doi: 10.1007/s00198-024-07195.
     PubMed     Abstract available
     
     
     
247. REGINSTER JY, Czerwinski E, Wilk K, Borowy P, et al
     Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis.
     Osteoporos Int. 2024 Jul 23. doi: 10.1007/s00198-024-07161.
     PubMed     Abstract available
     
     
     
248. PATRA S, Boro H, Porchezhian P, Khan N, et al
     Evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case-control study from India.
     Osteoporos Int. 2024 Jul 22. doi: 10.1007/s00198-024-07198.
     PubMed     Abstract available
     
     
     
249. LE HV, Van BW, Shahzad H, Teng P, et al
     Fracture liaison service-a multidisciplinary approach to osteoporosis management.
     Osteoporos Int. 2024 Jul 18. doi: 10.1007/s00198-024-07181.
     PubMed     Abstract available
     
     
     
250. SCHWARCZ Y, Yanover C, Rouach V, Luria S, et al
     Non-osteoporotic fractures are associated with increased risk of subsequent major osteoporotic fractures.
     Osteoporos Int. 2024 Jul 13. doi: 10.1007/s00198-024-07169.
     PubMed     Abstract available
     
     
     
251. PADERNO A, Ataide Gomes EJ, Gilberg L, Maerkisch L, et al
     Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review.
     Osteoporos Int. 2024 Jul 10. doi: 10.1007/s00198-024-07179.
     PubMed     Abstract available
     
     
     
252. JOHANSSON P, Kristjansdottir HL, Johansson H, Mellstrom D, et al
     Increased risk of hip and major osteoporotic fractures in 8463 patients who have undergone stem cell transplantation, a Swedish population-based study.
     Osteoporos Int. 2024 Jul 8. doi: 10.1007/s00198-024-07171.
     PubMed     Abstract available
     
     
     
253. MOBERG L, Jehpsson L, Nilsson PM, Rosengren B, et al
     Birth weight and birth length affect future fracture risk differently in men and women.
     Osteoporos Int. 2024 Jul 5. doi: 10.1007/s00198-024-07172.
     PubMed     Abstract available
     
     
     
254. KANIS JA, Harvey NC, Lorentzon M, Liu E, et al
     Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk.
     Osteoporos Int. 2024 Jul 3. doi: 10.1007/s00198-024-07162.
     PubMed     Abstract available
     
     
     
255. BENSKY MJ, Adler L, Banon T, Gabay L, et al
     Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews.
     Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07174.
     PubMed    
     
     
     
256. PARK SY, Ahn SH, Bae GH, Jang S, et al
     Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
     Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07159.
     PubMed     Abstract available
     
     
     
257. MCCARROLL K, Carroll T, Neville M, Fitzpatrick D, et al
     Delayed and significant hypercalcaemia due to teriparatide therapy: a case report and review.
     Osteoporos Int. 2024;35:1299-1302.
     PubMed     Abstract available
     
     
     June 2024
258. PU X, Liu B, Wang D, Xiao W, et al
     Opportunistic use of lumbar computed tomography and magnetic resonance imaging for osteoporosis screening.
     Osteoporos Int. 2024 Jun 28. doi: 10.1007/s00198-024-07164.
     PubMed     Abstract available
     
     
     
259. CORDOVA LA, Gonzalez-Quintanilla D, Heymann D
     Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?
     Osteoporos Int. 2024 Jun 27. doi: 10.1007/s00198-024-07173.
     PubMed    
     
     
     
260. EVERTS-GRABER J, Wenger M, Oser S, Studer U, et al
     The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland.
     Osteoporos Int. 2024 Jun 26. doi: 10.1007/s00198-024-07155.
     PubMed     Abstract available
     
     
     
261. HOLVIK K, Dahl C, Samuelsen SO, Sogaard AJ, et al
     Educational gradient in hip fracture incidence in Norway. The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
     Osteoporos Int. 2024 Jun 25. doi: 10.1007/s00198-024-07133.
     PubMed     Abstract available
     
     
     
262. BARZILAY JI, Buzkova P, Bielinski SJ, Cotch MF, et al
     The association of microvascular disease and endothelial dysfunction with vertebral trabecular bone mineral density : The MESA study.
     Osteoporos Int. 2024 Jun 24. doi: 10.1007/s00198-024-07152.
     PubMed     Abstract available
     
     
     
263. MUZZAMMIL M, Bhura S, Hussain AS, Bashir S, et al
     Undiagnosed vertebral fragility fractures in patients with distal radius fragility fractures: an opportunity for prevention of morbimortality in osteoporotic patients in developing countries.
     Osteoporos Int. 2024 Jun 20. doi: 10.1007/s00198-024-07149.
     PubMed     Abstract available
     
     
     
264. SO E, Juels C, Scott RT, Sietsema DL, et al
     A comparison of foot fractures relative to other fragility fractures: a review and analysis of the American Orthopaedic Association's Own the Bone Database.
     Osteoporos Int. 2024 Jun 18. doi: 10.1007/s00198-024-07153.
     PubMed     Abstract available
     
     
     
265. XU MZ, Lu K, Ye YW, Xu SM, et al
     Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis.
     Osteoporos Int. 2024 Jun 6. doi: 10.1007/s00198-024-07142.
     PubMed     Abstract available
     
     
     
266. KUMAR S, Gild ML, McDonald MM, Kim AS, et al
     A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
     Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07139.
     PubMed     Abstract available
     
     
     
267. LAROSE G, Al-Azazi S, Lix LM, Bohm E, et al
     Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysis.
     Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07131.
     PubMed     Abstract available
     
     
     
268. TAHMASBI F, Sadoughi F, Sheikhtaheri A, Zabihiyeganeh M, et al
     Developing fracture liaison service framework based on comparative analysis and scoping review.
     Osteoporos Int. 2024 Jun 3. doi: 10.1007/s00198-024-07091.
     PubMed     Abstract available
     
     
     
269. PLAIS N, Gallego-Bustos J, Mahillo-Fernandez I, Tome-Bermejo F, et al
     Letter to the editor.
     Osteoporos Int. 2024;35:1105-1106.
     PubMed    
     
     
     
270. GUO DM, Weng YZ, Yu ZH, Li SH, et al
     Semi-automatic proximal humeral trabecular bone density assessment tool: technique application and clinical validation.
     Osteoporos Int. 2024;35:1049-1059.
     PubMed     Abstract available
     
     
     
271. ZHOU L, Zhou H, Xu H, Sun X, et al
     Different bone health progression patterns and early-stage risk marker in glucocorticoid-treated ambulatory Duchenne muscular dystrophy.
     Osteoporos Int. 2024;35:997-1005.
     PubMed     Abstract available
     
     
     May 2024
272. DENG L, Shuai P, Liu Y, Yong T, et al
     Diagnostic performance of radiomics for predicting osteoporosis in adults: a systematic review and meta-analysis.
     Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07136.
     PubMed     Abstract available
     
     
     
273. PARK YB, Kim M, Nam HC, Jeon JW, et al
     Total knee arthroplasty and periprosthetic distal femoral fracture: looking beyond the osteoporosis to previous osteoporotic fracture.
     Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07138.
     PubMed     Abstract available
     
     
     
274. KNIGHT KJ, Fordham RJ, Crabtree NJ, Knapp KM, et al
     Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019-2023.
     Osteoporos Int. 2024 May 25. doi: 10.1007/s00198-024-07120.
     PubMed     Abstract available
     
     
     
275. CHEN Y, Miao Y, Zhang Q
     Association of combined healthy lifestyle factors with incident osteoporosis in patients with and without type 2 diabetes.
     Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07126.
     PubMed     Abstract available
     
     
     
276. YUE YS, Liu Y, Lu K, Shi Q, et al
     Outdoor walking, genetic predisposition, and the risk of incident osteoporosis among older adults: A prospective large population-based cohort study.
     Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07122.
     PubMed     Abstract available
     
     
     
277. MORENO-RABIE C, Fontenele RC, Oliveira-Santos N, Nogueira-Reis F, et al
     Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.
     Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07108.
     PubMed     Abstract available
     
     
     
278. WANG X, Zhao X
     Letter to the Editor regarding "Associations between ultra-distal forearm bone mineral density and incident fracture in women".
     Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07098.
     PubMed    
     
     
     
279. HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
     Author Response to OSIN-D-24-00437: Letter to the Editor regarding "Associations between ultra-distal forearm bone mineral density and incident fracture in women".
     Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07094.
     PubMed    
     
     
     
280. ANSARI H, Jaglal S, Cheung AM, Jain R, et al
     Osteoporosis management in adults with schizophrenia following index hip fracture event: a 10-year population-based retrospective cohort study, Ontario, Canada.
     Osteoporos Int. 2024 May 17. doi: 10.1007/s00198-024-07123.
     PubMed     Abstract available
     
     
     
281. LIN CJ, Lee YS, Yeh JH, Liu SJ, et al
     The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
     Osteoporos Int. 2024 May 15. doi: 10.1007/s00198-024-07097.
     PubMed     Abstract available
     
     
     
282. ALI A, Huszti E, Noordin S, Ali U, et al
     Examining treatment targets and equity in bone-active medication use within secondary fracture prevention: a systematic review and meta-analysis.
     Osteoporos Int. 2024 May 14. doi: 10.1007/s00198-024-07078.
     PubMed     Abstract available
     
     
     
283. KOBAYASHI T, Morimoto T, Ito K, Mawatari M, et al
     Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials.
     Osteoporos Int. 2024 May 11. doi: 10.1007/s00198-024-07118.
     PubMed     Abstract available
     
     
     
284. KUSAKABE T, Ishihara Y, Kitamura T, Yasoda A, et al
     Beneficial effects of romosozumab on bone mineral density and trabecular bone score assessed by dual-energy X-ray absorptiometry in a family with osteogenesis imperfecta.
     Osteoporos Int. 2024 May 8. doi: 10.1007/s00198-024-07089.
     PubMed    
     
     
     
285. XIAO X, Wu Q
     Enhanced fracture risk prediction: a novel multi-trait genetic approach integrating polygenic scores of fracture-related traits.
     Osteoporos Int. 2024 May 7. doi: 10.1007/s00198-024-07105.
     PubMed     Abstract available
     
     
     
286. LIU B, Ng CY, La PBD, Wong P, et al
     Osteoporosis and fracture risk assessment in adults with ischaemic stroke.
     Osteoporos Int. 2024 May 4. doi: 10.1007/s00198-024-07099.
     PubMed     Abstract available
     
     
     April 2024
287. PRAVEEN AD, Aspelund T, Ferguson SJ, Sigurethsson S, et al
     Refracture and mortality risk in the elderly with osteoporotic fractures: the AGES-Reykjavik study.
     Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07096.
     PubMed     Abstract available
     
     
     
288. GOLD DT, Beckett T, Deal C, James AL, et al
     Treatment patterns in women with postmenopausal osteoporosis using abaloparatide: a real-world observational study.
     Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07070.
     PubMed     Abstract available
     
     
     
289. WANG M, Seibel MJ
     Secondary fracture prevention in primary care: a narrative review.
     Osteoporos Int. 2024 Apr 23. doi: 10.1007/s00198-024-07036.
     PubMed     Abstract available
     
     
     
290. ZUBICK P, Dahlke S
     Family/caregiver influence on osteoporosis management for older people: an integrative review.
     Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07081.
     PubMed     Abstract available
     
     
     
291. AGARWAL AR, Kinnard MJ, Murdock C, Zhao AY, et al
     The cost-effectiveness of osteoporosis medications for preventing periprosthetic fractures following femoral neck fracture indicated hip arthroplasty: a break-even analysis.
     Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07085.
     PubMed     Abstract available
     
     
     
292. WU J, Li J, Yan Z, Yu X, et al
     Higher prevalence of thyroid-specific autoantibodies (TPOAb and TgAb) is related to a higher prevalence of fractures in females: results from NHANES 2007-2010.
     Osteoporos Int. 2024 Apr 12. doi: 10.1007/s00198-024-07083.
     PubMed     Abstract available
     
     
     
293. CHANDRAN M, Akesson KE, Javaid MK, Harvey N, et al
     Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.
     Osteoporos Int. 2024 Apr 8. doi: 10.1007/s00198-024-07059.
     PubMed     Abstract available
     
     
     
294. LANE J, Langdahl B, Stone M, Kurth A, et al
     Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials.
     Osteoporos Int. 2024 Apr 4. doi: 10.1007/s00198-024-07049.
     PubMed     Abstract available
     
     
     
295. GIELEN E, Aldven M, Kanis JA, Borgstrom F, et al
     Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.
     Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07043.
     PubMed     Abstract available
     
     
     
296. ANAGNOSTIS P, Lallas K, Pappa A, Avgeris G, et al
     The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies.
     Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07075.
     PubMed     Abstract available
     
     
     
297. FUJITA N, Ono Y, Hashimoto K, Kawamura Y, et al
     Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report.
     Osteoporos Int. 2024;35:733-736.
     PubMed     Abstract available
     
     
     
298. WHITING PS, Hare K, Krueger D, Borchardt G, et al
     Periprosthetic fractures are osteoporotic fractures: missed opportunities for osteoporosis diagnosis.
     Osteoporos Int. 2024 Apr 1. doi: 10.1007/s00198-024-07057.
     PubMed     Abstract available
     
     
     March 2024
299. KOBAYASHI T, Morimoto T, Mawatari M
     Factors influencing the measurement of sagittal spinopelvic alignment in patients with vertebral fractures.
     Osteoporos Int. 2024 Mar 29. doi: 10.1007/s00198-024-07063.
     PubMed    
     
     
     
300. CAI Y, Jun G, Zhuang X
     Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study.
     Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-023-07013.
     PubMed     Abstract available
     
     
     
301. DANAZUMI MS, Lightbody N, Dermody G
     Effectiveness of fracture liaison service in reducing the risk of secondary fragility fractures in adults aged 50 and older: a systematic review and meta-analysis.
     Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-024-07052.
     PubMed     Abstract available
     
     
     
302. LORENTZON M, Litsne H, Axelsson KF
     The significance of recent fracture location for imminent risk of hip and vertebral fractures-a nationwide cohort study on older adults in Sweden.
     Osteoporos Int. 2024 Mar 23. doi: 10.1007/s00198-024-07072.
     PubMed     Abstract available
     
     
     
303. LI D, Mao SS, Budoff MJ
     Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis.
     Osteoporos Int. 2024 Mar 22. doi: 10.1007/s00198-024-07040.
     PubMed     Abstract available
     
     
     
304. PARK HJ, Kim MG, Yoo YS, Lee B, et al
     Correction to: Determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: A systematic review and meta-analysis.
     Osteoporos Int. 2024 Mar 21. doi: 10.1007/s00198-024-07065.
     PubMed    
     
     
     
305. PLUSKIEWICZ W, Tabor E
     The comments on manuscript entitled 'Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study'.
     Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07056.
     PubMed    
     
     
     
306. DAS L, Laway BA, Sahoo J, Dhiman V, et al
     Bone mineral density, turnover, and microarchitecture assessed by second-generation high-resolution peripheral quantitative computed tomography in patients with Sheehan's syndrome.
     Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07062.
     PubMed     Abstract available
     
     
     
307. MERLIJN T, Swart KMA, Niemeijer C, van der Horst HE, et al
     The yield of routine laboratory examination in osteoporosis evaluation in primary care.
     Osteoporos Int. 2024 Mar 18. doi: 10.1007/s00198-024-07042.
     PubMed     Abstract available
     
     
     
308. TAGUCHI A
     Letters to the Editor for "Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study".
     Osteoporos Int. 2024 Mar 14. doi: 10.1007/s00198-024-07058.
     PubMed    
     
     
     
309. PARK HJ, Kim MG, Yoo YS, Lee BR, et al
     Determination of the Combined Effects of Asian Herbal Medicine with Calcium and/or Vitamin D Supplements on Bone Mineral Density in Primary Osteoporosis: A Systematic Review and Meta-Analysis.
     Osteoporos Int. 2024 Mar 13. doi: 10.1007/s00198-024-07061.
     PubMed     Abstract available
     
     
     
310. CRANDALL CJ, Larson J, Shadyab AH, LeBoff MS, et al
     Physical function trajectory after wrist or lower arm fracture in postmenopausal women: results from the Women's Health Initiative Study.
     Osteoporos Int. 2024 Mar 9. doi: 10.1007/s00198-024-07050.
     PubMed     Abstract available
     
     
     
311. HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
     Associations between ultra-distal forearm bone mineral density and incident fracture in women.
     Osteoporos Int. 2024 Mar 6. doi: 10.1007/s00198-024-07041.
     PubMed     Abstract available
     
     
     
312. CHEN L, Li C, Chen H, Xie Y, et al
     Cross-sectional studies of the causal link between asthma and osteoporosis: insights from Mendelian randomization and bioinformatics analysis.
     Osteoporos Int. 2024 Mar 2. doi: 10.1007/s00198-024-07037.
     PubMed     Abstract available
     
     
     February 2024
313. BLAY R, Flores LE, Kupzyk K, Waltman N, et al
     Twelve-month resistance and impact exercise program or risedronate provides a relative benefit to hip bone structure in postmenopausal women: results from a randomized controlled trial.
     Osteoporos Int. 2024 Feb 17. doi: 10.1007/s00198-023-07008.
     PubMed     Abstract available
     
     
     
314. PRAVEEN AD, Sollmann N, Baum T, Ferguson SJ, et al
     CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis.
     Osteoporos Int. 2024 Feb 14. doi: 10.1007/s00198-024-07029.
     PubMed     Abstract available
     
     
     
315. ZHANG H, Yang F, Cao Z, Xu Y, et al
     The influence of iron on bone metabolism disorders.
     Osteoporos Int. 2024;35:243-253.
     PubMed     Abstract available
     
     
     
316. YANG Q, He J, Yuan F
     Improvement of proportion of days covered for denosumab under implementation of clinical pharmacist adherence management system: normal and COVID-19 period.
     Osteoporos Int. 2024;35:309-316.
     PubMed     Abstract available
     
     
     
317. RAMCHAND SK, Tsai JN, Lee H, Sassana-Khadka G, et al
     The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.
     Osteoporos Int. 2024;35:255-263.
     PubMed     Abstract available
     
     
     January 2024
318. EBINA K, Nagayama Y, Kashii M, Tsuboi H, et al
     An investigation of the differential therapeutic effects of romosozumab on postmenopausal osteoporosis patients with or without rheumatoid arthritis complications: a case-control study.
     Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07019.
     PubMed     Abstract available
     
     
     
319. YU W, Guan WM, Hayashi D, Lin Q, et al
     Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique.
     Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07024.
     PubMed     Abstract available
     
     
     
320. CUNHA-SANTOS F, Augusto D, Pinto AS, Dinis SP, et al
     Predictors of atypical femoral fractures: experience of a Portuguese Fracture Liaison Service.
     Osteoporos Int. 2024 Jan 29. doi: 10.1007/s00198-024-07033.
     PubMed    
     
     
     
321. BENNETT MJ, Center JR, Perry L
     Establishing consensus recommendations for long-term osteoporosis care for patients who have attended an Australian fracture liaison service: a Delphi study.
     Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07014.
     PubMed     Abstract available
     
     
     
322. SILVA FF, Machado GR, Ribeiro ACM, Bonfiglioli KR, et al
     Damaged bone microarchitecture by Trabecular Bone Score (TBS) and low appendicular muscle mass: main risk factors for vertebral and non-vertebral fractures in women with long-standing rheumatoid arthritis.
     Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07026.
     PubMed     Abstract available
     
     
     
323. IKI M, Fujimori K, Nakatoh S, Tamaki J, et al
     Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwi
     Osteoporos Int. 2024 Jan 24. doi: 10.1007/s00198-024-07023.
     PubMed     Abstract available
     
     
     
324. JEON S, Yu D, Kim S, Kim SW, et al
     Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture.
     Osteoporos Int. 2024 Jan 23. doi: 10.1007/s00198-024-07025.
     PubMed     Abstract available
     
     
     
325. CAO X, Keyak JH, Sigurdsson S, Zhao C, et al
     A new hip fracture risk index derived from FEA-computed proximal femur fracture loads and energies-to-failure.
     Osteoporos Int. 2024 Jan 22. doi: 10.1007/s00198-024-07015.
     PubMed     Abstract available
     
     
     
326. BYUN SE, Kim H, Lee SY, Kim SM, et al
     Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017-2019.
     Osteoporos Int. 2024 Jan 19. doi: 10.1007/s00198-024-07022.
     PubMed     Abstract available
     
     
     
327. SKJODT MK, Nicolaes J, Smith CD, Olsen KR, et al
     Opportunistically identifiable vertebral fractures on routine radiological imaging predict mortality: observational cohort study.
     Osteoporos Int. 2024 Jan 18. doi: 10.1007/s00198-024-07017.
     PubMed     Abstract available
     
     
     
328. VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al
     A meta-analysis of previous falls and subsequent fracture risk in cohort studies.
     Osteoporos Int. 2024 Jan 17. doi: 10.1007/s00198-023-07012.
     PubMed     Abstract available
     
     
     
329. ZENG L, Li Y, Hong C, Wang J, et al
     Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies.
     Osteoporos Int. 2024 Jan 15. doi: 10.1007/s00198-023-06996.
     PubMed     Abstract available
     
     
     
330. LEUNG MTY, Turner JP, Marquina C, Ilomaki J, et al
     Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study.
     Osteoporos Int. 2024 Jan 10. doi: 10.1007/s00198-023-06974.
     PubMed     Abstract available
     
     
     
331. CHOO YW, Mohd Tahir NA, Mohamed Said MS, Makmor Bakry M, et al
     Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41.
     Osteoporos Int. 2024 Jan 9. doi: 10.1007/s00198-023-07005.
     PubMed     Abstract available
     
     
     
332. MULKERRIN P, O'Shea F, Fitzgerald G
     Comment on: Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
     Osteoporos Int. 2024 Jan 8. doi: 10.1007/s00198-023-07010.
     PubMed    
     
     
     December 2023
333. MCCARROLL K, Fitzpatrick D, McCormack M, Abdelfadil S, et al
     Falsely elevated parathyroid hormone in a patient with osteoporosis: a case report and review.
     Osteoporos Int. 2023 Dec 28. doi: 10.1007/s00198-023-07006.
     PubMed     Abstract available
     
     
     
334. CHEN H, Zhu X, Zhou Q, Pu X, et al
     Utility of MRI-based vertebral bone quality scores and CT-based Hounsfield unit values in vertebral bone mineral density assessment for patients with diffuse idiopathic skeletal hyperostosis.
     Osteoporos Int. 2023 Dec 27. doi: 10.1007/s00198-023-06999.
     PubMed     Abstract available
     
     
     
335. MAKRAS P, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, et al
     Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment.
     Osteoporos Int. 2023 Dec 26. doi: 10.1007/s00198-023-07000.
     PubMed    
     
     
     
336. DING W, Huang Y, Li G, Dong Y, et al
     Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma: from genetic and prospective evidence.
     Osteoporos Int. 2023 Dec 23. doi: 10.1007/s00198-023-07004.
     PubMed     Abstract available
     
     
     
337. MAGNO LAV, Tameirao DR, Alves LF, Guimaraes NS, et al
     Effect of recreational cannabis use on bone mineral density: a systematic review.
     Osteoporos Int. 2023 Dec 23. doi: 10.1007/s00198-023-06992.
     PubMed     Abstract available
     
     
     
338. CHAVASSIEUX P, Roux JP, Chapurlat R
     Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level.
     Osteoporos Int. 2023 Dec 22. doi: 10.1007/s00198-023-06972.
     PubMed     Abstract available
     
     
     
339. YOKOYAMA K, Ikeda N, Tanaka H, Ito Y, et al
     Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture.
     Osteoporos Int. 2023 Dec 18. doi: 10.1007/s00198-023-06976.
     PubMed     Abstract available
     
     
     
340. YOO JE, Huh Y, Kim E, Park SH, et al
     Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study.
     Osteoporos Int. 2023 Dec 14. doi: 10.1007/s00198-023-06983.
     PubMed     Abstract available
     
     
     
341. GUIMARAES GC, Coelho JBC, Silva JGO, de Sant'Ana ACC, et al
     Obesity, diabetes and risk of bone fragility: How BMAT behavior is affected by metabolic disturbances and its influence on bone health.
     Osteoporos Int. 2023 Dec 6. doi: 10.1007/s00198-023-06991.
     PubMed     Abstract available
     
     
     
342. HASSANABADI N, Berger C, Papaioannou A, Cheung AM, et al
     Geographic variation in bone mineral density and prevalent fractures in the Canadian longitudinal study on aging.
     Osteoporos Int. 2023 Dec 2. doi: 10.1007/s00198-023-06975.
     PubMed     Abstract available
     
     
     November 2023
343. NIZNIK JD, Kelley CJ, Fasth L, Colon-Emeric C, et al
     Deprescribing bisphosphonates for older adults with dementia: perspectives of caregivers.
     Osteoporos Int. 2023 Nov 18. doi: 10.1007/s00198-023-06967.
     PubMed     Abstract available
     
     
     
344. BEAUDART C, Sharma M, Clark P, Fujiwara S, et al
     Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.
     Osteoporos Int. 2023 Nov 13. doi: 10.1007/s00198-023-06955.
     PubMed     Abstract available
     
     
     
345. CHEN KH, Su CM, Liu WJ, Tzeng HE, et al
     The joint effects of physical activity and sleep duration on risk of osteoporosis in Taiwanese adult population: The Taiwan Biobank Study.
     Osteoporos Int. 2023 Nov 10. doi: 10.1007/s00198-023-06947.
     PubMed     Abstract available
     
     
     
346. KONNOPKA C, Buchele G, Jaensch A, Rothenbacher D, et al
     Evaluation of costs, osteoporosis treatment, and re-fractures in German collaborative orthogeriatric care after fragility fractures.
     Osteoporos Int. 2023 Nov 9. doi: 10.1007/s00198-023-06965.
     PubMed     Abstract available
     
     
     
347. NAJAFI S, Mohammadkhah F, Ebrahimi MM, Harsini PA, et al
     Effect of educational intervention on preventing osteoporosis in postmenopausal women.
     Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06962.
     PubMed     Abstract available
     
     
     
348. AGARWAL AR, Tarawneh O, Cohen JS, Gu A, et al
     The incremental risk of fragility fractures in aging men.
     Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06956.
     PubMed     Abstract available
     
     
     
349. CHEN Q, Tu Z, Ai Y, Li W, et al
     Forearm bone mineral density predicts screw loosening after lumbar fusion similar to lumbar Hounsfield unit value in patients with lumbar spondylolisthesis.
     Osteoporos Int. 2023 Nov 3. doi: 10.1007/s00198-023-06957.
     PubMed     Abstract available
     
     
     October 2023
350. HAN S, Kim S, Yeh EJ, Suh HS, et al
     Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women.
     Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06934.
     PubMed     Abstract available
     
     
     
351. INPAN R, Na Takuathung M, Sakuludomkan W, Dukaew N, et al
     Isoflavone intervention and its impact on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
     Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06944.
     PubMed     Abstract available
     
     
     
352. HEUCHERT J, Koziel S, Spinek AE
     Radiomorphometric indices of the mandible as indicators of decreased bone mineral density and osteoporosis - meta-analysis and systematic review.
     Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06949.
     PubMed     Abstract available
     
     
     
353. LOSCALZO E, See J, Bharill S, Yousefzadeh N, et al
     Growth hormone and testosterone delay vertebral fractures in boys with muscular dystrophy on chronic glucocorticoids.
     Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06951.
     PubMed     Abstract available
     
     
     
354. KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
     Correction to: Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
     Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06927.
     PubMed    
     
     
     
355. KOVACS CS
     Fraudulent, duplicate publication of pregnancy/lactation data in Osteoporosis International.
     Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06939.
     PubMed    
     
     
     
356. ZERAATTALAB-MOTLAGH S, Mortazavi AS, Ghoreishy SM, Mohammadi H, et al
     Association between total and animal proteins with risk of fracture: A systematic review and dose-response meta-analysis of cohort studies.
     Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06948.
     PubMed     Abstract available
     
     
     
357. PLAIS N, Bustos JG, Mahillo-Fernandez I, Tome-Bermejo F, et al
     Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment.
     Osteoporos Int. 2023 Oct 13. doi: 10.1007/s00198-023-06936.
     PubMed     Abstract available
     
     
     
358. GROVLE L, Haugen AJ, Johansen M, Hasvik E, et al
     The terminologies of transient, migratory, or localized osteoporosis, and bone marrow edema syndrome: a scoping review.
     Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06929.
     PubMed     Abstract available
     
     
     
359. YAN F, Wu L, Lang J, Huang Z, et al
     Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
     Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06925.
     PubMed     Abstract available
     
     
     
360. LI N, van den Bergh JP, Boonen A, Wyers CE, et al
     Cost-effectiveness analysis of fracture liaison services: a Markov model using Dutch real-world data.
     Osteoporos Int. 2023 Oct 3. doi: 10.1007/s00198-023-06924.
     PubMed     Abstract available
     
     
     
361. MAKRAS P, Yavropoulou MP, Polyzos SA, Papapoulos SE, et al
     The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection.
     Osteoporos Int. 2023 Oct 2. doi: 10.1007/s00198-023-06931.
     PubMed     Abstract available
     
     
     
362. OTEO-ALVARO A, Garcia CG, Sanchez AI, Santamaria CA, et al
     Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).
     Osteoporos Int. 2023;34:1799-1804.
     PubMed     Abstract available
     
     
     
363. BAGHERIFARD A, Hosseinzadeh A, Koosha F, Sheibani M, et al
     Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects.
     Osteoporos Int. 2023;34:1677-1701.
     PubMed     Abstract available
     
     
     September 2023
364. MAAS L, Raskin N, van Onna M, Cornelissen D, et al
     Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture.
     Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06906.
     PubMed     Abstract available
     
     
     
365. SOLOMON DH, Ruppert K, Cauley JA, Lian Y, et al
     The effect of starting metformin on bone mineral density among women with type 2 diabetes in the Study of Women's Health Across the Nation (SWAN).
     Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06915.
     PubMed     Abstract available
     
     
     
366. HUNG WC, Lin YL, Cheng TT, Chin WL, et al
     Establish and validate the reliability of predictive models in bone mineral density by deep learning as examination tool for women.
     Osteoporos Int. 2023 Sep 20. doi: 10.1007/s00198-023-06913.
     PubMed     Abstract available
     
     
     
367. FUJISHIMA R, Ushimaru S, Sumi H, Aso M, et al
     Effect of denosumab on bone mineral density in a postmenopausal osteoporotic woman with prolonged chronic mild hyponatremia.
     Osteoporos Int. 2023 Sep 19. doi: 10.1007/s00198-023-06898.
     PubMed    
     
     
     
368. LIU X, Makaroff KE, Almario CV, Khalil C, et al
     Determining patient preferences for the medical management of osteoporosis using conjoint analysis.
     Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06882.
     PubMed     Abstract available
     
     
     
369. ELWAKIL W, El Gaafary M, El Miedany Y
     Screening and management of osteoporosis: a survey of knowledge, attitude, and practice among healthcare professionals in Egypt-a study by the Egyptian Academy of Bone Health.
     Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06914.
     PubMed     Abstract available
     
     
     
370. CLIFTON GOLDNEY D, Pelegrin C, Jerkovich F, Longobardi V, et al
     Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series.
     Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06894.
     PubMed     Abstract available
     
     
     
371. LEE RH, Curtis J, Drake MT, Bobo Tanner S 4th, et al
     Association of prior treatment with nitrogen-containing bisphosphonates on outcomes of COVID-19 positive patients.
     Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06912.
     PubMed     Abstract available
     
     
     
372. LU K, Wu YM, Shi Q, Gong YQ, et al
     A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients.
     Osteoporos Int. 2023 Sep 12. doi: 10.1007/s00198-023-06905.
     PubMed     Abstract available
     
     
     
373. NICOLAES J, Liu Y, Zhao Y, Huang P, et al
     External validation of a convolutional neural network algorithm for opportunistically detecting vertebral fractures in routine CT scans.
     Osteoporos Int. 2023 Sep 7. doi: 10.1007/s00198-023-06903.
     PubMed     Abstract available
     
     
     
374. PENG T, Zeng X, Li Y, Li M, et al
     A study on whether deep learning models based on CT images for bone density classification and prediction can be used for opportunistic osteoporosis screening.
     Osteoporos Int. 2023 Sep 5. doi: 10.1007/s00198-023-06900.
     PubMed     Abstract available
     
     
     
375. LIU J, Tang Y, Peng B, Tian C, et al
     Bone mineral density is associated with composite dietary antioxidant index among US adults: results from NHANES.
     Osteoporos Int. 2023 Sep 4. doi: 10.1007/s00198-023-06901.
     PubMed     Abstract available
     
     
     
376. KARPUZ S
     Zoledronic acid-induced severe lymphopenia.
     Osteoporos Int. 2023;34:1653-1655.
     PubMed     Abstract available
     
     
     August 2023
377. MOAYYERI A, Warden J, Han S, Suh HS, et al
     Estimating the economic burden of osteoporotic fractures in a multinational study: a real-world data perspective.
     Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06895.
     PubMed     Abstract available
     
     
     
378. WANG J, Xing F, Sheng N, Xiang Z, et al
     Associations of dietary oxidative balance score with femur osteoporosis in postmenopausal women: data from the National Health and Nutrition Examination Survey.
     Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06896.
     PubMed     Abstract available
     
     
     
379. SHAHROUR E
     A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy).
     Osteoporos Int. 2023 Aug 30. doi: 10.1007/s00198-023-06876.
     PubMed    
     
     
     
380. BILLINGTON EO, Miyagishima RC, Hasselaar C, Arain M, et al
     Women's perspectives regarding osteoporosis, fracture risk, and pharmacologic treatment: a cross-sectional study.
     Osteoporos Int. 2023 Aug 22. doi: 10.1007/s00198-023-06890.
     PubMed     Abstract available
     
     
     
381. BARCELOS A, Goncalves J, Mateus C, Canhao H, et al
     Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective.
     Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06881.
     PubMed     Abstract available
     
     
     
382. HONG N, Shin S, Lee S, Rhee Y, et al
     Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis.
     Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06889.
     PubMed     Abstract available
     
     
     
383. ABDALBARY M, El-Husseini A
     Author response to: Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.
     Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06874.
     PubMed    
     
     
     
384. TURABI RY, Sheehan KJ
     Response letter to: "The importance of structural barriers of osteoporotic hip fracture in the elderly".
     Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06864.
     PubMed    
     
     
     
385. MARTINS MJ
     Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study. Osteoporos Int. 2023 Apr;34(4):763-774.
     Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06873.
     PubMed    
     
     
     
386. MEIJIDE H, Gredilla I, Cachorro I, Robert I, et al
     The importance of structural barriers of osteoporotic hip fracture in the elderly.
     Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06875.
     PubMed    
     
     
     
387. LI W, Zhao H, Zhou S, Xiong Z, et al
     Does vertebral osteoporosis delay or accelerate lumbar disc degeneration? A systematic review.
     Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06880.
     PubMed     Abstract available
     
     
     
388. KANIS JA, Johansson H, McCloskey EV, Liu E, et al
     Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.
     Osteoporos Int. 2023 Aug 11. doi: 10.1007/s00198-023-06870.
     PubMed     Abstract available
     
     
     
389. SEO DH, Jeong Y, Cho Y, Kim SH, et al
     Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults.
     Osteoporos Int. 2023 Aug 8. doi: 10.1007/s00198-023-06879.
     PubMed     Abstract available
     
     
     
390. FITZPATRICK D, Seebah S, Lannon R, Mc Carroll K, et al
     Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naive patients: two further cases.
     Osteoporos Int. 2023 Aug 1. doi: 10.1007/s00198-023-06869.
     PubMed    
     
     
     July 2023
391. HE D, Liu H, Wei W, Zhao Y, et al
     A longitudinal genome-wide association study of bone mineral density mean and variability in the UK Biobank.
     Osteoporos Int. 2023 Jul 27. doi: 10.1007/s00198-023-06852.
     PubMed     Abstract available
     
     
     
392. THERKILDSEN J, Rohde PD, Nissen L, Thygesen J, et al
     A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density.
     Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06857.
     PubMed     Abstract available
     
     
     
393. EVERTS-GRABER J, Bonel H, Lehmann D, Gahl B, et al
     Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
     Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06863.
     PubMed     Abstract available
     
     
     
394. MAZEDA C, Barcelos A
     Gender differences in osteoporosis.
     Osteoporos Int. 2023 Jul 20. doi: 10.1007/s00198-023-06858.
     PubMed    
     
     
     
395. TAN EH, Robinson DE, Jodicke AM, Mosseveld M, et al
     Drug utilization analysis of osteoporosis medications in seven European electronic health databases.
     Osteoporos Int. 2023 Jul 12. doi: 10.1007/s00198-023-06837.
     PubMed     Abstract available
     
     
     
396. SCHUMM AK, Craige EA, Arora NK, Owen PJ, et al
     Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis.
     Osteoporos Int. 2023 Jul 11. doi: 10.1007/s00198-023-06829.
     PubMed     Abstract available
     
     
     
397. HASEGAWA T
     Author response to OSIN-D-23-00510, "Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wo
     Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06835.
     PubMed    
     
     
     
398. SOMAY E
     Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really
     Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06821.
     PubMed    
     
     
     
399. JAVAID MK, Pinedo-Villanueva R, Shah A, Mohsin Z, et al
     The Capture the Fracture(R) Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit.
     Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06759.
     PubMed     Abstract available
     
     
     
400. SHEVROJA E, Reginster JY, Lamy O, Al-Daghri N, et al
     Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Dis
     Osteoporos Int. 2023 Jul 1. doi: 10.1007/s00198-023-06817.
     PubMed     Abstract available
     
     
     June 2023
401. SCHOUSBOE JT, Binkley N, Leslie WD
     Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture.
     Osteoporos Int. 2023 Jun 28. doi: 10.1007/s00198-023-06820.
     PubMed     Abstract available
     
     
     
402. MOON RJ, Reginster JY, Al-Daghri NM, Thiyagarajan JA, et al
     Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
     Osteoporos Int. 2023 Jun 23. doi: 10.1007/s00198-023-06827.
     PubMed     Abstract available
     
     
     
403. KADRI A, Binkley N, Hernando D, Anderson PA, et al
     Author response to letter to editor: OSIN-D-23-00474, "letter to the editor regarding 'Opportunistic use of lumbar magnetic resonance imaging for osteoporosis screening'".
     Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06808.
     PubMed    
     
     
     
404. PU X, Li H
     Letter to the editor regarding "Opportunistic Use of Lumbar Magnetic Resonance Imaging for Osteoporosis Screening".
     Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06801.
     PubMed    
     
     
     
405. LIU FC, Luk KC, Chen YC
     Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan.
     Osteoporos Int. 2023 Jun 16. doi: 10.1007/s00198-023-06818.
     PubMed     Abstract available
     
     
     
406. HUANG G, Chen X, Chen Y, Liu W, et al
     Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population.
     Osteoporos Int. 2023 Jun 12. doi: 10.1007/s00198-023-06807.
     PubMed     Abstract available
     
     
     
407. PASKINS Z, Moult A, Corp N, Bastounis A, et al
     Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise.
     Osteoporos Int. 2023 Jun 9. doi: 10.1007/s00198-023-06806.
     PubMed     Abstract available
     
     
     
408. HESARI E, Sanjari M, Mansourzadeh MJ, Fahimfar N, et al
     Osteoporosis medication adherence tools: a systematic review.
     Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06789.
     PubMed     Abstract available
     
     
     
409. HAGINO H, Moriwaki K, Wada T, Osaki M, et al
     Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study.
     Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06816.
     PubMed     Abstract available
     
     
     
410. KUNIHARA T, Tohmori H, Tsukamoto M, Kobayashi M, et al
     Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan.
     Osteoporos Int. 2023;34:1101-1109.
     PubMed     Abstract available
     
     
     May 2023
411. LIN SM, Lin JY, Tu YK, Wu CH, et al
     Association between bisphosphonate use and stroke risk: a meta-analysis.
     Osteoporos Int. 2023 May 30. doi: 10.1007/s00198-023-06781.
     PubMed     Abstract available
     
     
     
412. LU K, Wu YM, Shi Q, Gong YQ, et al
     The impact of acute-phase reaction on mortality and re-fracture after zoledronic acid in hospitalized elderly osteoporotic fracture patients.
     Osteoporos Int. 2023 May 29. doi: 10.1007/s00198-023-06803.
     PubMed     Abstract available
     
     
     
413. GOLD LS, Suri P, O'Reilly MK, Kallmes DF, et al
     Mortality among older adults with osteoporotic vertebral fracture.
     Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06796.
     PubMed     Abstract available
     
     
     
414. ZHU K, Hunter M, James A, Lim EM, et al
     Relationships between longitudinal changes in body composition and bone mineral density in middle-to-older aged Australians.
     Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06773.
     PubMed     Abstract available
     
     
     
415. LAI SW
     Adipopenia associated with osteoporosis.
     Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06797.
     PubMed    
     
     
     
416. KWON H, Han KD, Kim BS, Moon SJ, et al
     Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study.
     Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06800.
     PubMed     Abstract available
     
     
     
417. RASHIDI MM, Saeedi Moghaddam S, Azadnajafabad S, Heidari-Foroozan M, et al
     Low bone mineral density, a neglected condition in North Africa and Middle East: estimates from the Global Burden of Disease Study, 1990-2019.
     Osteoporos Int. 2023 May 23. doi: 10.1007/s00198-023-06778.
     PubMed     Abstract available
     
     
     
418. KONDAPALLI AV, Kamanda-Kosseh M, Williams JM, Shiau S, et al
     Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study.
     Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06793.
     PubMed     Abstract available
     
     
     
419. YANG H, Bai J, Li L, Yang Y, et al
     Association of C-peptide level with bone mineral density in type 2 diabetes mellitus.
     Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06785.
     PubMed     Abstract available
     
     
     
420. AGARWAL AR, Cohen JS, Tarawneh OH, Gu A, et al
     The impact of prior fragility fractures on long-term periprosthetic fracture risk following total knee arthroplasty.
     Osteoporos Int. 2023 May 11. doi: 10.1007/s00198-023-06746.
     PubMed     Abstract available
     
     
     
421. AVGERINOU C, Petersen I, Clegg A, West RM, et al
     Trends in incidence of recorded diagnosis of osteoporosis, osteopenia, and fragility fractures in people aged 50 years and above: retrospective cohort study using UK primary care data.
     Osteoporos Int. 2023 May 10. doi: 10.1007/s00198-023-06739.
     PubMed     Abstract available
     
     
     
422. METRAILLER A, Hans D, Lamy O, Gonzalez Rodriguez E, et al
     Heel quantitative ultrasound (QUS) predicts incident fractures independently of trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus Study.
     Osteoporos Int. 2023 May 8. doi: 10.1007/s00198-023-06728.
     PubMed     Abstract available
     
     
     April 2023
423. HO-PHAM LT, Nguyen HG, Nguyen-Pham SQ, Hoang DK, et al
     Longitudinal changes in bone mineral density during perimenopausal transition: the Vietnam Osteoporosis Study.
     Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06757.
     PubMed     Abstract available
     
     
     
424. RISKA BSL, Gunnes N, Stigum H, Finnes TE, et al
     Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
     Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06752.
     PubMed     Abstract available
     
     
     
425. MOON RJ, Green HD, D'Angelo S, Godfrey KM, et al
     The effect of pregnancy vitamin D supplementation on offspring bone mineral density in childhood: a systematic review and meta-analysis.
     Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06751.
     PubMed     Abstract available
     
     
     
426. BENNETT MJ, Center JR, Perry L
     Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study.
     Osteoporos Int. 2023 Apr 24. doi: 10.1007/s00198-023-06748.
     PubMed     Abstract available
     
     
     
427. HILL EC, O'Donnell L
     Low bone mineral density is associated with fatty liver disease and respiratory illness in a pediatric mortality sample.
     Osteoporos Int. 2023 Apr 21. doi: 10.1007/s00198-023-06760.
     PubMed     Abstract available
     
     
     
428. CHANG CM, Chen YC, Wu WT, Lin TK, et al
     Association between clinical use of nifedipine and the risk of osteoporosis: a nationwide retrospective cohort study.
     Osteoporos Int. 2023 Apr 20. doi: 10.1007/s00198-023-06756.
     PubMed     Abstract available
     
     
     
429. HASEGAWA T, Kawakita A, Ueda N, Funahara R, et al
     Correction to: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday rea
     Osteoporos Int. 2023 Apr 13. doi: 10.1007/s00198-023-06745.
     PubMed    
     
     
     
430. PONZANO M, Tibert N, Brien S, Funnell L, et al
     Publisher Correction: International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures.
     Osteoporos Int. 2023 Apr 10. doi: 10.1007/s00198-023-06717.
     PubMed    
     
     
     
431. ICONARU L, Charles A, Baleanu F, Moreau M, et al
     Selection for treatment of patients at high risk of fracture by the short versus long term prediction models - data from the Belgian FRISBEE cohort.
     Osteoporos Int. 2023 Apr 6. doi: 10.1007/s00198-023-06737.
     PubMed     Abstract available
     
     
     
432. KHAN AA, AbuAlrob H, Al-Alwani H, Ali DS, et al
     Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators.
     Osteoporos Int. 2023 Apr 4. doi: 10.1007/s00198-022-06640.
     PubMed     Abstract available
     
     
     
433. TANG Y, Zhang L, Ye D, Zhao A, et al
     Causal relationship between Type 1 diabetes and osteoporosis and fracture occurrence: a two-sample Mendelian randomization analysis.
     Osteoporos Int. 2023 Apr 3. doi: 10.1007/s00198-023-06734.
     PubMed     Abstract available
     
     
     
434. MATTICK LJ, Bea JW, Hovey KM, Wactawski-Wende J, et al
     Follicle-stimulating hormone is associated with low bone mass in postmenopausal women.
     Osteoporos Int. 2023;34:693-701.
     PubMed     Abstract available
     
     
     March 2023
435. LEGRAND A, Autrusseau F, Bandiaky ON, Idiri K, et al
     Promising diagnostic performance of CBCT-based TOMOSTEOp algorithm in osteoporosis: toward a complementary populational screening tool managed by dentists?
     Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06724.
     PubMed    
     
     
     
436. NICKEL B, Krueger D, Borchardt G, Andersen L, et al
     Intraoperative physician assessment of bone: correlation to bone mineral density.
     Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06729.
     PubMed     Abstract available
     
     
     
437. GOEL H, Binkley N, Hans D, Leslie WD, et al
     Bone density and trabecular bone score to predict fractures in adults aged 20-39 years: a registry-based study.
     Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06722.
     PubMed     Abstract available
     
     
     
438. LIN Z, Shi G, Liao X, Liu W, et al
     Effect of pulmonary function on bone mineral density in the United States: results from the NHANES 2007-2010 study.
     Osteoporos Int. 2023 Mar 23. doi: 10.1007/s00198-023-06727.
     PubMed     Abstract available
     
     
     
439. BINKLEY N, Nickel B, Anderson PA
     Periprosthetic fractures: an unrecognized osteoporosis crisis.
     Osteoporos Int. 2023 Mar 20. doi: 10.1007/s00198-023-06695.
     PubMed     Abstract available
     
     
     
440. BRUHN R, Pedersen AB, Heide-Jorgensen U, Ehrenstein V, et al
     Epidemiology of male osteoporosis in Denmark (1996-2018).
     Osteoporos Int. 2023 Mar 13. doi: 10.1007/s00198-023-06720.
     PubMed     Abstract available
     
     
     
441. EISMAN JA, Cortet B, Boolell M, Ionescu-Ittu R, et al
     Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.
     Osteoporos Int. 2023 Mar 6. doi: 10.1007/s00198-022-06627.
     PubMed     Abstract available
     
     
     
442. HANS D, McDermott M, Huang S, Kim M, et al
     Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension.
     Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06708.
     PubMed     Abstract available
     
     
     
443. TALEVSKI J, Gianoudis J, Bailey CA, Ebeling PR, et al
     Effects of an 18-month community-based, multifaceted, exercise program on patient-reported outcomes in older adults at risk of fracture: secondary analysis of a randomised controlled trial.
     Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06693.
     PubMed     Abstract available
     
     
     
444. HU J, Li Y, Wang Z, Li X, et al
     Association of plant-based dietary patterns with the risk of osteoporosis in community-dwelling adults over 60 years: a cross-sectional study.
     Osteoporos Int. 2023 Mar 1. doi: 10.1007/s00198-023-06700.
     PubMed     Abstract available
     
     
     February 2023
445. JUNG SY, Cho EB, Han KD, Jung JH, et al
     Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea.
     Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06715.
     PubMed     Abstract available
     
     
     
446. HE D, Pan C, Zhao Y, Wei W, et al
     Exome-wide screening identifies novel rare risk variants for bone mineral density.
     Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06710.
     PubMed     Abstract available
     
     
     
447. XIAO X, Wu Q
     Ethnic disparities in fracture risk assessment using polygenic scores.
     Osteoporos Int. 2023 Feb 25. doi: 10.1007/s00198-023-06712.
     PubMed     Abstract available
     
     
     
448. YE C, Lee K, Leslie WD, Lin M, et al
     Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event.
     Osteoporos Int. 2023 Feb 2. doi: 10.1007/s00198-023-06690.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge.